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14 Abstract Neurodevelopmental disorders such as epilepsy,
15 intellectual disability (ID), and autism spectrum disorders
16 (ASDs) occur in over 2 % of the population, as the result of
17 genetic mutations, environmental factors, or combination of
18 both. In the last years, use of large-scale genomic techniques
19 allowed important advances in the identification of
20 genes/loci associated with these disorders. Nevertheless,
21 following association of novel genes with a given disease,
22 interpretation of findings is often difficult due to lack of
23 information on gene function and effect of a given mutation
24 in the corresponding protein. This brings the need to vali-
25 date genetic associations from a functional perspective in
26 model systems in a relatively fast but effective manner. In
27 this context, the small nematode, Caenorhabditis elegans,
28 presents a good compromise between the simplicity of cell
29 models and the complexity of rodent nervous systems. In
30 this article, we review the features that make C. elegans a
31 good model for the study of neurodevelopmental diseases.
32 We discuss its nervous system architecture and function as
33 well as the molecular basis of behaviors that seem important
34 in the context of different neurodevelopmental disorders.
35 We review methodologies used to assess memory, learning,
36 and social behavior as well as susceptibility to seizures in
37 this organism. We will also discuss technological progresses
38 applied in C. elegans neurobiology research, such as use of
39 microfluidics and optogenetic tools. Finally, we will present
40 some interesting examples of the functional analysis of
41genes associated with human neurodevelopmental disorders
42and how we can move from genes to therapies using this
43simple model organism.
44Keywords Neurodevelopment .C. elegans . Autism .
45Epilepsy . Intellectual disability
46Neurodevelopmental Disorders: Past, Present,
47and Future
48Development of a fully functional nervous system com-
49prises many cellular and molecular events, which need to
50occur in a precise and ordered manner. These include cell
51proliferation; migration; programmed cell death; cell differ-
52entiation (involving morphological and biochemical special-
53izations); establishment of contacts between neurons,
54synapses, and pruning of less efficient ones; and also estab-
55lishment of specialized relationships between neurons and
56other cell types. Disturbances in any of these steps will lead
57to loss of viability, if severe, or to neurodevelopmental
58disorders, if more subtle. Neurodevelopmental disorders as
59a group occur in over 2 % of the population and comprise
60intellectual disability (ID), epilepsy, autism spectrum disor-
61ders (ASDs), specific reading or writing impairments, hy-
62peractivity, and attention deficit disorder, among others.
63Schizophrenia is also often seen as a neurodevelopmental
64disturbance manifesting only in adulthood. These disorders
65have an important impact in society, affecting not only the
66patients but whole families, especially when the care network
67is not well structured. They may result from genetic factors or
68from environmental interference with normal development
69process, as occurs, for instance, in the case of fetal alcoholic
70syndrome. Some of the effects of the environment may even
71be potentiated by a susceptible genetic background.
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72 Recently, important advances in our knowledge of genetic
73 causes of neurodevelopmental diseases have emerged as a
74 result of application of novel genomic analysis technologies
75 (reviewed in [1]). To illustrate this, the genetic basis of disease
76 can now be identified in up to 80 % of patients with ID, when
77 applying array comparative genomic hybridization and whole
78 exome sequencing techniques. Additionally, many gene vari-
79 ants putatively associated with more complex, multifactorial
80 neurodevelopmental disturbances have also been identified in
81 the last years using genetic linkage and association analyses.
82 Nevertheless, following identification of novel gene variants
83 potentially causing the disease of interest, difficulty is often
84 the interpretation of findings, namely, lack of information on
85 gene function and on the effect of a given mutation in the
86 corresponding protein. This brings the need for model systems
87 that can be used to study genes and mutations of interest in a
88 relatively fast but effective manner.
89 Studies of Human Neurodevelopmental Genes in Lower
90 Organisms
91 Geneticists have harnessed the power of model organisms
92 for understanding of human gene function for many years
93 now, with flies, yeast, and mouse leading the way. In a
94 simpler perspective, human neuronal cell lines can be a very
95 interesting model to study the function of genes identified as
96 associated with human neurodevelopmental diseases, given
97 presence of majority of molecular components. However,
98 given their lack of integration in functional circuits; lack of
99 interaction with other cell types, also relevant for function of
100 the nervous system; and absence of a behavioral output that
101 allows assessment of effectiveness of the circuits, for many
102 studies, there is the need to use a whole organism approach.
103 Mice have been used for this purpose with very encouraging
104 results: globally, the structure of the human and murine
105 nervous systems bears significant resemblance and even at
106 the behavioral level, paradigms have been developed to
107 analyze traits that are thought to be parallel between these
108 two species. Rat models are even more advantageous
109 (particularly in cognitive and social studies), but the tools
110 for genetic manipulation have lagged behind. Disadvantages
111 of the use of rodents are their relatively high maintenance
112 costs and difficulty/cost/time consumption of their genetic
113 manipulation. On the other hand, the complex structure of
114 their nervous system, which is certainly advantageous for
115 some studies, also presents serious constraints when trying
116 to dissect molecular events leading to disease. In this
117 perspective, organisms with simpler nervous systems and
118 genetic amenability provide an elegant framework for the
119 study of gene function and malfunction.
120 A simpler species in which neurobiology of memory has
121 been widely studied, but in which genetic manipulation has
122not been so developed, is Aplysia californica. Aplysia has a
123relatively small number of neurons, and many of them are
124enormous, allowing electrophysiological studies, individual
125neuronal manipulation, and observation of their neuronal
126architecture. Moreover, its neurons are able to form and
127store memories, have plasticity, and for several of them, a
128functional role has been determined [2]. In contrast, Dro-
129sophila melanogaster is a model in which genetic tools are
130highly developed and which has been increasingly used in
131behavioral genetic studies, the advantage being that it has a
132brainlike structure and complex behaviors that can be
133analyzed. Moreover, identification of specific neuronal
134populations and neuron-to-behavior output has advanced
135greatly in recent years [3]. Zebrafish is also a simple model
136that has the main advantage of being a vertebrate with a high
137degree of genetic homology with mammals. Because it has a
138brain, zebrafish is often envisaged as the bridge between
139Drosophila/worms and murine models. This animal model
140has been widely used to study human neurological disorders
141because of its low maintenance cost, rapid life cycle, rapid
142external embryonic development, and optical clarity of em-
143bryos and larvae, which allows observation of the nervous
144system in vivo. In addition, both gain- (overexpression of
145mutated proteins) and loss-of-function (morpholinos; zinc
146finger nuclease deletions, etc.….) approaches can be con-
147sidered to study gene function [4]. Finally, for very simple
148functional genomic studies, yeast and other fungi can also
149be used, with the advantage of simplicity and ease of genetic
150manipulation but with clear limitations when it comes to
151understanding function of a gene within the nervous system.
152Caenorhabditis elegans as a Simple Model to Study
153Complex Neuronal Phenomena
154C. elegans provides a good compromise between complex-
155ity of vertebrates like mouse and extreme simplicity of yeast
156and is a reference model in studying function and malfunc-
157tion of the nervous system. This animal presents key advan-
158tages that make it unique in the field of neurosciences: first,
159the well-described neuronal lineage and interconnectivity
160provides an exceptional set up for the study of neuronal
161mechanisms. Second, amenability to genetic manipulation
162allows identification of genes important for neuronal forma-
163tion, migration, and activity. Third, its transparency in com-
164bination with existence of specific transgenic reporter
165strains allows in vivo monitoring of particular neuronal
166events, with possibility of correlating temporal patterns of
167neuronal activity with behavioral outcomes. Herein, we
168will describe the model, tools available in the field, and
169some of the remarkable contributions of this nematode
170for the understanding of nervous system function and
171dysfunction, and its underlying genetics, with particular
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172 focus on neurodevelopmental disorders such as epilepsy,
173 ASDs, and ID.
174 C. elegans Nervous System
175 While neuronal wiring diagrams in higher species such as
176 rodents often present ambiguities and misinterpretations inher-
177 ent to their complexity, simplicity of the C. elegans nervous
178 system and its well-described anatomy and interconnectivity
179 make this model an attractive and complementary tool in the
180 field of neuroscience. The hermaphrodite C. elegans has 302
181 neurons divided in surprising 118 distinct neuronal classes and
182 56 glial cells, altogether comprising 37 % of all the somatic
183 cells in the worm [5, 6]. Neuronal classes include 39 classes of
184 predicted sensory neurons, 27 of motor neurons, and the
185 remainder as interneurons [7]. Lineage and morphology have
186 been described in detail [6], and there are fluorescent reporter
187 genes for almost every neuron with exquisite specificity
188 (some examples are in Table 1 and Fig. 1) [5, 8, 9].
189 Worm synapses (around 7,000) occur en passant, i.e.,
190 synaptic boutons are formed along the axon shaft [10, 11].
191 The presynaptic site bears much resemblance to those of
192 vertebrate nervous system, but the postsynaptic region ap-
193 pears to be simpler. The number of synapses between each
194 partner can go up to 19 but normally is around five synapses
195 [10, 11]. It is also possible to observe synapses in vivo by
196 using fluorescent reporter molecules such as synaptobrevin
197 (SNB-1) [12], an integral membrane protein of synaptic
198 vesicles. Importantly, this marker not only allows determina-
199 tion of synaptic density because synaptobrevin puncta corre-
200 lates with the number of synaptic vesicles in ultrastructural
201 studies but also is a measure of steady-state rates of vesicles
202 exocytosis and endocytosis (intensity of synaptobrevin in
203 axons) [13, 14]. In an elegant RNA interference (RNAi)
204 screening study that aimed to identify genes regulating GABA
205synapses, use of SNB-1::GFP marker allowed researchers to
206obtain insight on the nature of different neuronal defects
207[15]. By changing the promoter that controlled the marker,
208one could assess synaptic condition in either inhibitory
209(GABAergic) or excitatory (cholinergic) inputs of the neuro-
210muscular junction (NMJ). Use of additional markers such as
211the postsynaptic UNC-49 GABAA receptor even allowed
212researchers to distinguish pre- from postsynaptic defects
213[15]. Moreover, specific markers of the active zone (special-
214ized synaptic structures that mediate neurotransmitter release)
215were developed, such as SYD-2::GFP, which allows their
216direct visualization [16] and isolation of mutants with
217defective active zone morphology [17, 18].
t1:1 Table 1 Some examples of C. elegans strains expressing a fluorescent marker in a specific group of neurons. All referred strains are available at the
Caenorhabditis Genetics Center (CGC)
t1:2 Strain Genotype Description Expression pattern
t1:3 OH441 otIs45 V Integrated Ex[unc-119::GFP] Pan-neuronal marker
t1:4 NM440 unc-104(e1265); jsIs1 jsIs1[pSB120 (snb-1::GFP); pRF4 (rol-6(su1006))] Nerve ring, ventral cord, dorsal cord
t1:5 SK4005 zdIs5 zdIs5 [mec-4::GFP + lin-15(+) (pSK1)] Touch neurons
t1:6 LX929 vsIs48 vsIs48[unc-17::GFP] All cholinergic neurons
t1:7 EG1285 lin-15B(n765); oxIs12 oxIs12 [unc-47p::GFP + lin-15(+)] All GABAergic neurons
t1:8 CZ333 juIs1 juIs1 [unc-25p::snb-1::GFP + lin-15(+)] Presynaptic terminals of GABAergic DD and
VD motor neurons and RME neurons
t1:9 NM306 jsIs1 jsIs1[pSB120(snb-1::GFP) + pRF4(rol-4(su1006))] Nerve ring, ventral cord and dorsal cord
t1:10 OH7547 otIs199 otIs199 [cat-2::GFP + rgef-1(F25B3.3)::dsRed +
rol-6(su1006)]
Dopaminergic neurons and dsRed expressed
pan-neuronally
t1:11 BZ555 egIs1 egIs1[Pdat-1::GFP] Dopaminergic neuronal soma and processes
Fig. 1 Confocal pictures of commonly used C. elegans strains that
express GFP in specific neurons. a Pan-neuronal expression of GFP
observed in OH441 strain. This strain expresses GFP under the control
of unc-119 promoter. The function of UNC-119 is still unknown, but
this protein is necessary for neuronal formation and migration, is
expressed since early embryonic stages until adulthood, and is present
in nearly all neurons. b Strain LX929 expressing GFP in all cholinergic
neurons. The fluorescent protein is in frame with UNC-17, a synaptic
vesicle acethylcholine transporter. c Expression of GFP in all
GABAergic neurons in strain EG1285. The fluorescent marker is
expressed under the control of unc-47 promoter; UNC-47 is a
transmembranar vesicular GABA transporter. Scale 50 μm
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218 C. elegans presents a stereotyped synaptic positioning,
219 both the number and type of synaptic connections formed
220 being similar between individuals (75 % reproducibility) [6,
221 10, 11, 19]. Yet, recent studies demonstrate that, as in
222 mammals, synaptic activity may play a decisive role in
223 shaping synaptic patterns after the initial pattern is established.
224 As an example, mutants with reduced cholinergic synaptic
225 transmission present enhanced sprouting of cholinergic
226 SAB neurons [20].
227 Considering its simplicity, invariant neuronal network,
228 and all the markers available, it is fairly easy to score
229 (neuro)developmental defects in C. elegans, making this
230 model a powerful tool to identify genes involved in neuronal
231 formation and maturation and axonal outgrowth and migra-
232 tion. Despite its simplicity, C. elegans neurons use an array
233 of classical neurotransmitters similar to those of mammals
234 such as acetylcholine, dopamine, serotonin, GABA, and
235 glutamate, whereas histamine, epinephrine, and norepineph-
236 rine seem to be absent [5].
237 Acetylcholine is the major excitatory neurotransmitter at
238 nematode NMJs, and more than a third of the cells release
239 acetylcholine, which is important for locomotion, egg
240 laying, feeding, and male mating [21]. Aldicarb inhibits
241 acetylcholinesterase, the enzyme responsible for hydrolysis
242 of acetylcholine, culminating in buildup of this neurotrans-
243 mitter, causing paralysis. Thus, several genes involved in
244 biosynthesis and metabolism of acetylcholine have been
245 identified by presence of the “Ric” phenotype (for resistance
246 to inhibitors of cholinesterase) in response to aldicarb or
247 other similar compounds [22].
248 As in mammals, fast excitatory neurotransmission in C.
249 elegans is mainly glutamatergic, and both excitatory and
250 inhibitory ionotropic glutamate receptors (iGluR) exist
251 [23–25]. Glutamate-gated chloride channels are also pres-
252 ent, though less studied and well understood [26]. iGluR are
253 important for locomotion, feeding, defecation, and recently,
254 were shown to be a determinant for learning and memory
255 formation. For example, eat-4 encodes a vesicular glutamate
256 transporter highly expressed in sensory neurons that respond
257 to tapping [27–29], and deletion of this gene induces a more
258 rapid habituation to tap [29, 30], suggesting a crucial role for
259 glutamate in this type of learning. Interestingly, complemen-
260 tation with the human counterpart reverts the impairment,
261 suggesting a common functional role [31]. Furthermore, in
262 certain paradigms, worms can learn to associate paired
263 stimuli and this is dependent on glr-1 [32].
264 Bioamines, such as canonical dopamine and serotonin
265 and the invertebrate-specific octopamine and tyramine, act
266 in both neurons and muscles to affect egg laying, pharyngeal
267 pumping, locomotion, and learning [33]. Such as in mam-
268 mals, dopamine D1 and D2 receptors (dop-1 and dop-3,
269 respectively) can act antagonistically, and their balance in
270 specific dopaminergic neurons tightly controls response to
271food [33, 34]. Similar to vertebrates and in further support of
272common neurotransmitter systems, in C. elegans, exposure
273to 6-OHDA induces programmed cell death in dopaminer-
274gic neurons [35–37].
275GABA is an important inhibitory neurotransmitter in C.
276elegans, but in contrast to vertebrates where it acts at syn-
277apses of the central nervous system, in nematodes, GABA
278acts primarily at neuromuscular synapses, being important
279for locomotion, defecation, and foraging [38]. GABA is
280expressed in 26 of the 302 neurons present in C. elegans,
281and the proteins involved in GABA biosynthesis and transport
282are remarkably conserved (Fig. 2). Such as in mammals, there
283are two types of receptors, GABAA and GABAB, based on
284sequence similarity [39–42].
285In addition to conventional neurotransmitter molecules,
286to date, 113 genes encoding over 250 distinct neuropeptides
287have been identified in worms [43]. These neuropeptides are
288involved in a wide range of worm behaviors such as loco-
289motion, egg laying, social behavior, and ethanol response
290[43] and are expressed in both nervous and non-nervous
291tissues. Of these, 40 encode insulinlike peptides (ins family),
29231 encode FMRFamide-related peptides (FLPs), and 42
293encode other types of peptides (neuropeptidelike peptides,
294NLPs). Neuropeptides are short amino acid sequences that
295act directly (as primary neurotransmitters) or indirectly to
296modulate synaptic function. Identification of neuropeptides
297and their receptors is a complicated task since peptides may
298functionally overlap and are able to bind to various receptors,
299depending on the physiological condition of the animal.
300Among the most studied neuropeptides are members of the
301insulinlike family, such as ins-1, highly expressed in neuronal
302tissues and that have been shown to regulate reproductive
303growth and longevity [44]. Under harsh environmental con-
304ditions, C. elegans undergoes an alternative life stage, called
305dauer, and this decision is dependent on the activity of an
306insulinlike receptor, daf-2, and daf-28, a beta-type insulin
307[45]. Involvement of this signaling pathway in longevity,
308discovered in C. elegans, has also been identified in
309Drosophila and mammals [46–48].
310While it is undeniable that neurotransmitter systems and
311neuropeptides are significantly conserved in C. elegans, we
312cannot overlook the fact that worm findings do not always
313mimic the human picture nor are easily translatable. As an
314example, fluoxetine, a serotonin reuptake inhibitor, is an
315antidepressant in humans and other mammals, while in
316worms, it is a potent stimulator of egg-laying [49–51]; these
317two apparently unlike phenotypes are the result of similar
318neuronal control by serotonin. In mammals, cocaine primar-
319ily exerts its behavioral effects by inhibiting dopamine re-
320uptake, leading to a stimulant effect. In contrast, in worms,
321cocaine leads to hypolocomotion and its effects are not
322dependent on dopamine, being mediated by the ionotropic
323serotonin receptor MOD-1 [52]. These pitfalls cannot be
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324 neglected but this nematode is still an attractive and com-
325 plementary model to study cellular and molecular mecha-
326 nisms underlying neuronal phenomena. Furthermore, its
327 tractability, genetic amenability, and feasibility of doing
328 large-scale analysis have led to substantial use of this model
329 in drug and/or genetic screenings. Among all the models, C.
330 elegans is the most cost-effective to use in high-throughput
331 analysis and still offers the advantage of being a multicellular
332 organism in comparison with cell culture systems or yeast
333 (reviewed in [53]).
334 A Simple Organism Presenting Complex Behaviors
335 In contrast to its simplicity, in terms of neuronal architec-
336 ture, C. elegans presents a repertoire of relatively complex
337 behaviors. Worms can sense hundreds of different odors
338 even at a very low concentration, discriminate among them,
339 and generate behavioral responses that are appropriate to the
340 cue. Similarly, C. elegans is able to sense a variety of
341 noxious stimuli, including low pH, heavy metals, deter-
342 gents, and high osmolarity [54–58], using specific sensory
343 neurons identified by laser ablation studies (reviewed in [7]).
344 Simplicity of the neuronal circuit allowed identification of
345 neurons (and genes) involved in sensing and discrimination
346 of several of these compounds. Interestingly, worms present
347 some degree of olfactory adaptation given that naïve ani-
348 mals will respond more than preexposed animals to a variety
349 of signals. Moreover, C. elegans is capable of learning the
350 odors of different bacteria and avoid strains that make them
351 ill [59]; these learned olfactory behaviors are associated
352 with neurochemical changes that induce behavioral (re)
353modeling. Curiously, C. elegans sensory perception is also
354able to regulate its longevity, suggesting that in nature,
355lifespan may be regulated by environmental cues rather than
356being determined solely genetically [60], a finding later
357confirmed in Drosophila [61].
358Pioneering studies have proven that worms are able to
359learn and present both short- and long-term memory under-
360lying the nonassociative form of learning—habituation [29,
36130, 62, 63]. Later, evidence showed that worms also present
362classical conditioning/associative learning using different
363types of stimuli (chemosensory and thermosensory) [32,
36464, 65]. As an example, worms chemotax to NaCl if previ-
365ously associated with food [66, 67]. Similarly, in a temper-
366ature gradient plate, worms will migrate to the food-
367associated temperature with remarkable accuracy [64, 68].
368Conversely, animals can also make a negative association if
369the attractant was previously associated with an aversive
370stimulus such as starvation [69]. In mammals, learning is
371strongly dependent on experience-dependent synaptic
372changes in glutamatergic synapses. Likewise, glutamatergic
373transmission is important for behavioral plasticity and
374learning in C. elegans. For example, glr-1 (AMPA-type
375glutamate receptor) mutations block olfactory associative
376and nonassociative learning in C. elegans [30, 32, 70]. As
377mentioned before, eat-4, encoding a vesicular glutamate
378transporter, is crucial for tap habituation learning [30].
379Similar to other species, distributed training (blocks of
380stimuli separated by longer resting periods) appears to
381be fundamental for long-term memory formation in C.
382elegans, in contrast with massed training (similar num-
383ber of stimuli in just one block) [71]. C. elegans goes
384beyond simple learning and memory, presenting context
Fig. 2 Evolutionary conserved GABAergic signaling. The proteins
involved in the metabolism of GABA and its receptors are remarkably
conserved in humans, mice, Drosophila, and C. elegans. Mutations in
GAD1 have been associated with recessive cerebral palsy, a condition
in which patients often present seizures. Murine knockout models for
Gad1 and Gad2 also display seizures. Wild type worms are resistant to
proconvulsing effects of pentylenetetrazol (PTZ); however, knockout
animals for unc-25 (GAD1/2 ortholog) present PTZ-induced convulsions.
Drosophila deletion of Gad1 gene is lethal. Mutations in GABAA
receptors have been associated with epilepsy in humans. In mice, deletion
of both GABAA and GABAB increases seizure susceptibility. Worm
mutants for GABAA receptor unc-49 also present severe PTZ-induced
convulsions. On the contrary, Drosophila Rdl knockouts are resistant to
picrotoxin (PTX)-induced seizures. [137, 143, 277, 293–298]
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385 conditioning that is sensitive to latent inhibition and
386 extinction (reviewed in [7]).
387 C. elegans also presents some degree of social interac-
388 tion, and this is controlled by the neuropeptide Y (NPY)
389 receptor (NPR-1). Some strains, upon encountering
390 food/bacteria, reduce locomotion and disperse in the bacte-
391 ria lawn and feed individually, whereas other strains move
392 fast across the lawn and aggregate [72]. A single nucleotide
393 substitution in the receptor was shown to be sufficient to
394 transform the isolated strains to become social. In mammals,
395 NPY and its receptors are involved in regulation of food
396 consumption, anxiety, and stress resilience (reviewed in
397 [73]), a somewhat different role from that in nematodes.
398 Yet, recent work suggests that social isolation can induce
399 expression changes in NPY in mammals [74] and that
400 administration of an antagonist of NPY receptor subtype 2
401 (Y2R) can revert nicotine-induced social anxiety [75],
402 suggesting that NPY can also play a key role in social
403 behavior in higher species.
404 Cutting Edge Tools in the Field
405 Due to its size and easy and unexpensive maintenance and
406 tractability, C. elegans is suitable to large genetic and drug
407 screenings. This is a noteworthy benefit of using this model
408 in the initial study of several disorders, including those of
409 the nervous system. Generation of knockout and transgenic
410 strains is a relatively straightforward process and certainly
411 less time- and money-consuming than in other species.
412 Apart from classical mutagenesis (chemically induced or
413 by radiation), we can also take advantage of RNAi, a tech-
414 nique that is well established in worms and works for most
415 genes. However, systemic delivery of RNAi (usually by
416 feeding worms with bacteria expressing the interest dsRNA)
417 occasionally masks pertinent neuronal phenotypes and com-
418 monly neurons are refractory to classic RNAi [76]. Since
419 RNAi is a powerful tool to ascertain gene function, several
420 groups have tried to overcome difficulty of achieving effi-
421 cient neuronal RNAi silencing in C. elegans either by using
422 specific RNAi-sensitive strains [77] or simply based on the
423 expression under neuronal specific promoters of sense and
424 antisense RNAs corresponding to the gene of interest [78].
425 Others have developed a knockdown technique based on the
426 in vivo expression of heritable inverted-repeat genes. This
427 approach allows effective gene inactivation in the nervous
428 system in a time-specific manner using inducible promoters,
429 for example. Moreover, stable lines harboring the transgene
430 can be easily maintained [79]. Besides deletion/knockdown
431 of specific genes, increasing evidence suggests that several
432 neurodevelopmental disorders present a dosage defect rather
433 than a loss-of-function mutation. In this perspective, C.
434 elegans is still a very attractive model, since it is fairly easy
435to create transgenic animals and control expression of genes
436with temporal and cellular specificity by use of specific
437promoters.
438In the last years, several technical improvements have
439been implemented in the study of C. elegans nervous sys-
440tem, some of them simple to set up and some other requiring
441a significant optimization process. Live imaging is particu-
442larly attractive and simple to use in C. elegans considering
443its transparency and well-described anatomy. In addition to
444fluorescent markers that tag specific neuronal populations,
445one can monitor neuronal excitability in vivo and in freely
446moving animals by live calcium imaging [80]. For example,
447calcium imaging studies determined that the AWC neuron
448responds to temperature changes and that response thresh-
449olds differ depending on previously experienced tempera-
450ture [81]. Using the same technique, others have shown that
451the AFD neuron transmits both stimulatory and inhibitory
452temperature signals and that the activity of this neuron is
453compromised in animals depleted for CREB, a protein nec-
454essary for memory and learning [82]. This technique allows
455multiple neuronal recording and temporal correlation of
456neuronal activity but it is always dependent on imaging
457methods and is often inadequate to detect subthreshold
458membrane potential changes [83]. Other precise but drasti-
459cally more invasive methods have been adopted, such as
460electrophysiological measurements, though several con-
461straints exist considering the highly pressurized C. elegans
462body and the small size of its neuronal cell bodies (reviewed
463in [84]). Nevertheless, with careful dissection and some
464training, it is possible to obtain reliable data using this
465technique. Patch clamping was initially performed in the
466pharynx, in which the contraction (as in other fast muscles)
467is controlled by changes in membrane electrical potential
468because it was easier to identify and access. By recording
469pharyngeal activity, several studies have identified muta-
470tions in presynaptic proteins [85] and ion channels [86].
471Later studies were performed in exposed neurons from
472dissected animals [87] and some were even able to record
473touch response currents from PLM mechanosensory neu-
474rons [88]. Electrophysiological recording of both endoge-
475nous excitatory and inhibitory postsynaptic currents of the
476NMJ was an excellent tool to identify important genes in the
477control of GABA or acetylcholine release [89]. An adapta-
478tion of this technique was also applied to record currents
479from head neurons with success [90–92].
480Besides genetic manipulation of selected neuronal sub-
481types, it is possible to perform specific neuronal laser abla-
482tion in C. elegans in order to better dissect the function of a
483particular neuron or group of cells. This technique was used
484with success to scrutinize the neural circuit underlying ha-
485bituation [93, 94], thermotaxis [95, 96], and head-touch-
486mediated backward movements [93, 97]. Manipulations of
487the timing of laser ablation during the training process of the
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488 animals even allowed researchers to understand the kinetics
489 of habituation [94]. Genetically induced cell death is also
490 possible in worms through, for example, ectopic expression
491 of a dominant version of the mec-4 allele, which encodes a
492 subunit of a candidate mechanotransducing channel.
493 Overexpression of mec-4-dominant allele is thought to ele-
494 vate ion influx through the channel, leading to vacuolation
495 of several cell types, including neurons and muscular cells
496 [98]. Another example is use of light-inducible and tissue-
497 selective expression of mini singlet oxygen generator
498 (miniSOG), a newly engineered protein that generates sin-
499 glet oxygen upon blue light excitation, leading to cellular
500 death without detectable damages to surrounding tissues
501 [99]. More recently, laser ablation has emerged as an excel-
502 lent tool to study the process of neuronal regeneration.
503 Using high-energy pulses, it is possible to severe axons
504 (axotomy) and then perform subsequent regeneration
505 studies [100, 101].
506 Pioneering techniques such as optogenetics have also
507 been employed in worms with great success [102–104].
508 First, by manipulating the release of acetylcholine or GABA
509 at the NMJ using targeted expression of channel rhodopsin-
510 2, researchers were capable of analyzing neurotransmission
511 with high temporal precision [105, 106]. Later, researchers
512 developed a new system that allows manipulation of neural
513 activity with high spatial and temporal resolution, enabling
514 control of locomotion in real time [107]. Further expansion
515 of this technique by combination with microfluidics tech-
516 nology and computer automation was developed in order to
517 reach higher throughput and improve standardization and
518 consistency in data gathering. In addition, it is possible to
519 infuse drugs during optogenetic manipulations using
520 microfluidics, providing a significant contribution for the
521 study of synaptic function, for example [106]. Other opsins,
522 namely, archaerhodopsin-3, a neuronal silencer, were
523 recently applied in the study of the C. elegans nervous
524 system [108].
525 Recently, a high-throughput microfluidic approach has
526 been used for automatic identification and sorting of C.
527 elegans mutants with possible neurodevelopmental or
528 neurodegenerative phenotypes by using a GFP marker for
529 GABAergic motor neurons, with impressive speed and
530 efficacy [109].
531 C. elegans in the Study of Human Disorders
532 Despite its evolutionary distance from mammals, C. elegans
533 possesses thousands of genes orthologous to humans [110].
534 Worms have allowed insight into molecular mechanisms
535 underlying neurodegenerative disorders such as tauopathies
536 [111, 112], Alzheimer's disease [113–115], Parkinson's
537 disease [116, 117], polyglutamine disorders [118–122],
538juvenile neurolipofuscinosis [123], and amyotrophic lateral
539sclerosis [124], among others [125]. Most of the models
540involve transgenic expression of the human protein
541containing the mutation in specific tissues/neurons. For
542example, overexpression of an expanded polyglutamine
543tract in C. elegans neurons induces protein aggregation in
544vivo, and selective neuronal toxicity and motility defects
545[118, 126], equivalent to humans and mouse models. Pan-
546neuronal expression of mutated tau caused progressive
547motor uncoordination and accumulation of insoluble
548hyperphosphorylated tau in C. elegans. These animals
549presented substantial neurodegeneration, with axonal dis-
550ruption and presynaptic defects [112, 126]. This model
551was later used to mechanistically dissect tau-induced
552neurodegeneration and to identify drugs/genes that inhibit
553tau toxicity [111, 127–130].
554Reverse genetics is another way of dissecting the biolog-
555ical role of a given gene and to better understand how loss of
556function mutations originates specific neuronal deficits.
557Mutations in presenilin genes cause one form of aggressive
558familial Alzheimer's disease. The two worm orthologous
559genes, sel-12 and hop-1, are required for correct morphology
560and function of two cholinergic neurons involved in temper-
561ature memory formation [115]. Interestingly, insertion of the
562wild type human gene, but not a mutated form, is able to revert
563neuronal deficits and memory impairment, suggesting an
564overlapping function between worm and human coun-
565terparts [115].
566However, this remarkable resemblance of the model with
567the human picture is not always obvious. In humans, muta-
568tions in either PKD1 or PKD2 genes cause almost indistin-
569guishable clinical symptoms, leading to polycystic kidney
570disease (PKD). Mice PKD models develop cysts in the
571kidney and other organs, similarly to humans. Deletion of
572worm orthologous genes, lov-1 and pkd-2, provided appar-
573ently discrepant and unrelated outcomes. No differences
574were found in the very rudimentary excretory system of C.
575elegans mutants; rather, lov-1 mutation affected mating be-
576havior in male worms [131]. This mating defect was due to
577dysfunctional cilia, and amazingly, later findings have
578shown that PKD proteins were expressed in cilia of kidney
579cells and that cilliar dysfunction could be responsible for the
580formation of cysts [132]. Whereas at first glance the findings
581in worms were odd, they certainly contributed to the under-
582standing of the biological process underlying PKD. These
583results are quite interesting in the light of recent evidence
584suggesting that many human neurodevelopmental problems
585are linked to mutations in primary cilia formation (ciliopaties)
586[133], making C. elegans an appealing model to study the
587molecular basis of these disorders.
588In fact and apart from being a great model to study the
589mechanisms of neurodegeneration, worms are very appeal-
590ing in the study of neurodevelopment disorders such as
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591 epilepsy, ID, and ASDs, considering the existing know-how
592 of neuronal connectivity in this animal. Whereas environ-
593 ment can play a fundamental role in development of these
594 disorders, numerous studies have shown that they have a
595 strong genetic basis, with either monogenic or polygenic
596 etiology. However, though various genetic studies
597 pinpointed specific regions associated with these disorders,
598 the functional validation of the findings has often been
599 neglected. In fact, for a large proportion of the genes found
600 to be associated with epilepsy, ID, and ASDs, nothing is
601 known about their function or consequences of their muta-
602 tion in the nervous system. C. elegans could be envisaged as
603 an appealing biological platform, and the argument that C.
604 elegans is too simple and limited in the behavioral repertoire
605 to study these complex disorders is being abandoned in the
606 light of evidence previously discussed. First, C. elegans
607 displays complex behaviors such as learning and habit for-
608 mation and even presents some degree of social interaction;
609 second, the neurotransmitters/receptors and the basis of
610 neuronal mechanisms are remarkably conserved, and thus,
611 the neurobiological basis of human disease can be explored
612 in detail in this model. In the next section, we will give
613 some insights on emerging worm models in the study of
614 the molecular mechanisms underlying epilepsy, ASDs,
615 and ID.
616 C. elegans as a Model to Study Epilepsy
617 Epilepsy is estimated to affect 1–2 % of the population
618 worldwide, and around 40 % of the cases are thought to
619 have a genetic basis. Epilepsy is characterized by repeated
620 seizures (or convulsions), which are episodes of disturbed
621 brain activity, i.e., abnormal, excessive, or hypersynchronous
622 neuronal activity in the brain. Mutations in several genes have
623 been linked to different types of epilepsy, including many
624 genes that code for protein subunits of either voltage-gated
625 or ligand-gated ion channels [134–136]. Numerous genetically
626 engineered mice/rats have been developed to study epilepsy
627 and to better understand the contribution of specific genetic
628 mutations for the development of the disease [137–142].
629 Other cases of idiopathic-generalized epilepsy are com-
630 patible with a multigenic mode of inheritance and are most
631 likely the result of additive interaction of multiple suscepti-
632 bility genes contributing to disease. However and although
633 every year several genetic associations are reported, most
634 lack biological/functional validation. This flaw is a conse-
635 quence of the high cost, in terms of money and time, of
636 creating novel genetically modifiable murine mutant models
637 for each gene. In this context, simpler and genetically ame-
638 nable animal models such as worms are essential tools in
639 dissection of gene function and contribute to the understand-
640 ing of phenotype(s)/genotype relationships (Table 2).
641Seizures are caused by an unbalance in either the excit-
642atory and/or inhibitory input. In this context, simplicity of
643the C. elegans locomotor circuit may be crucial in studying
644seizure susceptibility. Whereas cholinergic innervation ex-
645cites muscles to contract alternately on the ventral or dorsal
646side, it simultaneously activates GABAergic inhibition to
647relax muscles on the opposite side. Wild type worms do not
648naturally display seizures, but null mutants for unc-43, a
649calcium/calmodulin-dependent serine/threonine kinase II
650(CaMKII) that regulates synaptic plasticity, were reported
651to present spontaneous convulsions [143].
652Somehow contradictory to the evidence in rodents, re-
653searchers found that wild type animals are resistant to
654GABA(A) receptor antagonist Pentylenetetrazol (PTZ), a
655potent compound that induces seizures in mammals. How-
656ever, in specific sensitized genetic backgrounds, PTZ can
657produce different types of convulsions, depending on mol-
658ecules and circuits affected. For example, unc-25 (GABA
659synthesis) mutants display repetitive contractions in the
660head, while unc-43 mutants present full-body convulsions
661(Fig. 2) [143]. The definitive proof of concept for the use of
662C. elegans to study epilepsy is the confirmation that the
663epilepticlike phenotype was a result of the abnormal syn-
664chronous activity of specific neurons. Using calcium imag-
665ing, researchers found that unc-43 animals displayed
666aberrant intestinal calcium oscillations that were reflected
667in abnormal defecation rhythm [144], raising the hypothesis
668that the same could occur in neurons, increasing suscepti-
669bility to seizures.
670A mutation (gain of function) in a neuronal acetylcholine
671receptor, acr-2, causes spontaneous muscle convulsions in
672C. elegans due to cholinergic overexcitation accompanied
673with a decreased GABAergic inhibition in the locomotor
674circuit [145]. Mutations in human acetylcholine receptors
675have also been associated with epilepsy [146]. Additional
676studies have shown that this epilepsylike phenotype is de-
677pendent on the activity of the TRPM nonselective cation
678channel gtl-2, which plays a role in ion homeostasis. Re-
679searchers have suggested that the convulsions were the
680result of a local ionic imbalance [145] and that glt-2 loss
681of function could counterweigh the excitation–inhibition
682imbalance caused by acr-2 (rather than affecting basal syn-
683aptic transmission), probably through ion level modifica-
684tion. In further support of this hypothesis, they show that
685altering Zn2+ homeostasis (but no Mg2+), had an anticon-
686vulsant effect, analogously to glt-2 loss of function. These
687promising and groundbreaking results may be translated
688into the human picture, since: (1) TRPM channels from
689other species also show permeability to divalent cations,
690including Zn2+ [147], and (2) manipulation of Zn2+ can
691activate acetylcholine receptors while inhibiting some
692GABA receptors [148, 149]. This study revealed a new role
693for ion homeostasis in seizure susceptibility and highlighted
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694TRPM channels as new players in this process, which can
695now be further explored in higher organisms and eventually
696used to develop novel pharmacological approaches.
697Another study has shown that increasing temperature in
698combination with exposure to higher levels of salts (NaCl
699and MgCl2) triggers abnormal neuronal bursts in C. elegans.
700Baccoside A, a molecule found in extracts of the plant
701Bacopa monnieri, which has been shown to inhibit excit-
702atory neurotransmission by blockade of calcium channels,
703significantly reduced seizure/convulsion at higher tempera-
704tures, eventually by modulating calcium entry in the cells
705[150]. Moreover, T-type Ca2+ channel mutant cca-1 does
706not present seizures at any stage, suggesting that additional
707studies are required to dissect how this molecule works and
708the contribution of these channels for epilepsy.
709The CHRNA7 gene encodes the subunit alpha 7 of
710nicotinic acetylcholine receptors (nAChRs), members of a
711superfamily of ligand-gated ions mediating fast signal trans-
712mission at synapses. CHRNA7 has been associated with
713several neurodevelopmental disorders, namely, epilepsy,
714ID, and schizophrenia [151, 152]. CHRNA7 is a very strong
715candidate gene for epilepsy involvement, as genes encoding
716other subunits of nAChRs, e.g., CHRNA2, CHRNA4, and
717CHRNB2, are known to be associated with autosomal-
718dominant nocturnal frontal lobe epilepsy [153]. C. elegans
719possesses one of the largest nAChR families known for any
720organism and a combination of genetic, microarray, physi-
721ological, and reporter gene expression studies has added
722greatly to our understanding of the components of nematode
723muscle and neuronal nAChR subtype [154]. The C. elegans
724ortholog of CHRNA7 is acr-16 [155, 156], which encodes a
725similar subunit and works as a ligand-gated ion channel that
726is required for the major fast cholinergic excitatory current
727at C. elegans NMJ [157]. One elegant study has shown that
728in the NJM, one single stimulus is able to induce prominent
729long-lasting depression in acetylcholine motor neurons. This
730phenomenon is highly dependent on desensitization of the
731postsynaptic acetylcholine nicotinic receptor ACR-16 but
732not on its counterpart acetylcholine levamisole receptor
733UNC-38 [158]. Acr-16 mutants presented slower synaptic
734depression in comparison with wild type animals,
735suggesting that acr-16 plays a key role in the balance of
736excitatory and inhibitory inputs. Interestingly, similarities
737between worm and human nAChRs go beyond receptor
738function. The conserved Wnt pathway seems to be crucial
739for correct translocation of some types of nAChR into the
740pre- or postsynaptic membranes. In mammals, Wnt7a regu-
741lates presynpatic localization of α7-nAChRs [158]. Likewise,
742in worms, Wnt ligand CWN-2 binds to CAM-1/LIN-17 (Ror
743receptor tyrosine kinase/Frizzled) heteromeric receptors,
744activating downstream effector DSH-1 (disheveled), which
745regulates ACR-16 translocation into the postsynaptic
746membrane [159]. Mutants of all of these players present
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747 accumulation of nonsynaptic ACR-16 and a significant reduc-
748 tion in synaptic current (Fig. 3b). However and despite this
749 evidence suggesting altered excitatory–inhibitory synaptic
750 balance, it remains to be determined if these mutants present
751 enhanced seizure susceptibility.
752 STXBP1 (syntaxin-binding protein 1) encodes a neuronal
753 specific syntaxin-binding protein, the mammalian homolog
754 of the C. elegans unc-18 gene [160]. Mutations in STXBP1
755 have been found to lead to autosomal dominant epilepsy and
756 ID [161]. The C. elegans unc-18 gene was first identified as
757 being required for maintenance of acetylcholine levels
758 [162]. Unc-18 is required for neurotransmitter release and
759 regulation of vesicle exocytosis via SNARE interaction
760 (Fig. 3a) [163, 164]. Accordingly, worms lacking functional
761 unc-18 show resistance to paralysis induced by aldicarb, an
762 acetylcholinesterase inhibitor [15]. This mechanism is evo-
763 lutionarily conserved, and as has been shown for unc-18,
764STXPB1 also binds to syntaxin-1, a SNARE protein in-
765volved in synaptic vesicle docking and fusion, and seems
766to act in the control of vesicle docking as well as the
767regulation of the vesicle fusion rate [165, 166]. In addition,
768it has previously been shown that mice lacking Munc18-1
769suffer from complete loss of neurotransmitter release from
770synaptic vesicles throughout development [167]. Aldicarb
771resistance can suggest a different neuronal excitability in
772these mutants, which would be interesting to explore in the
773context of seizure susceptibility.
774Lissencephaly is a nervous system disorder characterized
775by a “smooth brain,” lacking convolutions or gyri due to
776abnormal neuronal migration and poor survival of cortical
777neurons during development. Lissencephaly can be caused
778by mutations in the TUBA1A, LIS1, ARX, DCX, and RELN
779genes [168–174], among others, and several point mutations
780in these genes have been identified; importantly, patients
Fig. 3 Conserved neuronal pathways between C. elegans and humans,
which are relevant in the context of different neurodevelopmental
disorders. a At the presynaptic site, the conserved SNARE complex
mediates vesicle fusion and neurotransmitter release to the synaptic
cleft (1). STXPB1 (UNC-18 ortholog) binds to the SNARE protein
STX1 (UNC-64 ortholog) (2) regulating this process. Mutations in
STXPB1 are associated with epilepsy and intellectual disability.
NLG-1 and NRX-1 are the C. elegans orthologs of neuroligins and
neurexins, which are conserved cell adhesion proteins essential for
synapse formation, maturation, and stability (3), and have been impli-
cated in autism spectrum disorders. b Representative scheme of a
cholinergic synapse between a motor neuron and a muscle cell in C.
elegans. The translocation of nicotinic acetylcholine (ACh) receptors
(nAChRs) may require conserved members of the Wnt signaling path-
way in worms and humans. In C. elegans, CWN-2 (Wnt ligand; Wnt5
ortholog) binds to CAM-1/LIN-17 heteromeric receptors (1) (CAM-1:
Ror receptor tyrosine kinase ortholog; LIN-17: frizzled ortholog),
which activate downstream signal transduction molecule DSH-1
(disheveled (DVL) ortholog) (2). This pathway is necessary for correct
translocation of nAChR ACR-16 to the postsynaptic synapse (3).
Mutants for all of these genes present a reduction in synaptic current
(6) (an example of an ACh-evoked current in cam-1(−) is shown). This
Wnt-dependent translocation pathway seems to be conserved in
humans, since Wnt7 is required for presynaptic localization of
nACHRs in hippocampal neurons. ACh binds to either levamisole-
type receptor UNC-38 (4) (ortholog of CHRNB2) or to nicotinic-type
receptor ACR-16 (5) (ortholog of CHRNA7). 6 ACh induces rapid and
complete desensitization of nicotinic ACR-16 receptors (unc-38(−);
acr-16(+)), whereas its effect in levamisole UNC-38 receptors is less
pronounced (acr-16(−);unc-38(+)). This is translated into faster and
slower synaptic depression in unc-38 and acr-16 mutants, respectively.
This disturbance of excitatory–inhibitory balance may increase seizure
susceptibility in worms. In humans, several mutations in different
nAChRs have been associated with epilepsy. Human genes are
depicted in blue and worm orthologs in green. [151–153, 158, 159,
161, 182–184, 186, 278, 280]
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781 often suffer from intractable epilepsy. C. elegans lis-1 mu-
782 tants present more than 70 % of lethality, and the survivors
783 present marked seizure susceptibility when exposed to PTZ
784 [143], which works by lowering a threshold of GABAergic
785 response, revealing sensitized neuronal states, which would
786 otherwise not manifest in normal conditions. No major
787 defects were observed in neuronal architecture, but severe
788 presynaptic defects in GABAergic vesicle distribution
789 were found in these mutants [143]. Later studies have
790 analyzed mutants for other genes of the lis-1 pathway
791 and identified further “seizure-sensitive” genetic backgrounds
792 [175].
793 LIS-1 interacts with dynein, a well-characterized motor
794 protein, regulator of microtubules and involved in vesicle
795 and organelle transport. Considering the fact that integrity of
796 neural cytoskeleton is essential for regulation of intrinsic
797 neuronal activity, it is not so surprising that dynein mutants
798 also present enhanced PTZ sensitivity [175]. Likewise, mu-
799 tants for Rac GTPases, actin polymerization regulators,
800 demonstrated a robust behavioral response to PTZ and also
801 exhibited hypersensitivity to aldicarb (an acetylcholinester-
802 ase inhibitor), suggesting a deficit in inhibitory neurotrans-
803 mission [176]. Aldicarb causes body paralysis, resulting
804 from accumulation of acetylcholine at the NMJ; hence,
805 mutations that reduce synaptic transmission cause resistance
806 to aldicarb and vice versa. Another study has identified
807 several endocrine molecules and kinases that regulate
808 GABA transmission in worms, which inactivation increased
809 activity of body muscles, which is directly controlled by
810 GABAergic neurons [15]. Of the 90 positive candidate
811 genes, 21 had previously been associated with seizures,
812 reflecting the value of this model in the study of seizure
813 susceptibility [15].
814 Treating seizure-susceptible strains with antiepileptic
815 compounds would go in further support of the use of C.
816 elegans in the study of epilepsy. However, pharmacological
817 results in C. elegans in this regard are not so straightforward
818 to interpret. Anticonvulsants such as valproic acid,
819 ethosuximide, or trimethadione, significantly extend the life
820 span of C. elegans [177, 178], a peculiar phenotype that is
821 not easily translatable to the human context. Interestingly,
822 combined treatment of animals with valproic acid and
823 trimethadione produced an additive effect in longevity,
824 suggesting different signaling pathways, and suggested that
825 modulation of neuronal activity may control longevity sig-
826 nals [177]. Indeed, these compounds modulate neuronal
827 activity in worms, since it was found that trimethadione
828 treatment caused hypersensitivity to aldicarb, indicative of
829 neuromuscular activity stimulation [178]. We believe that
830 the studies about the effects of these drugs in C. elegans can
831 go beyond behavioral evaluation. For example, valproic
832 acid functions as a histone deacetylase inhibitor and has
833 been exploited in the context of several pathologies,
834including cancer. By doing a cross-species functional genomic
835approach and in an attempt to improve therapeutic efficacy of
836this drug, Forthun et al. have identified novel conserved
837sensitizers and synthetic lethal interactors of valproic acid
838[179]. A similar approach could be employed to identify
839seizure susceptibility/resilience pathways.
840Studies with proconvulsant drugs have originated find-
841ings that are more straightforward to analyze. PTZ is able to
842elicit seizures in genetically sensitive backgrounds. More-
843over, levamisole, known to activate neuronal nAChRs,
844which is able to provoke seizures in mammals [180, 181],
845induces hypercontracted paralysis of wild type nematodes,
846usually followed by relaxation and death.
847Worms and Social Behavior: Relevance for the Study
848of Autism Spectrum Disorders
849ASDs comprise a range of conditions, sometimes classified
850as pervasive developmental disorders, which involve one or
851more of the following characteristics: (1) abnormal social
852behavior, (2) deficits in communication, and (3) presence of
853stereotyped and repetitive behaviors and obsession with
854routines (DSM-IV). Due to inherent complexity of ASD
855symptoms, the use of C. elegans as a model system to study
856this group of disorders is controversial. However, since
857altered neuronal migration/connectivity or deficits in
858synaptic transmission has been proposed to be at the basis
859of etiology of numerous cases of ASDs, even if C. elegans
860does not fully recapitulate core symptoms of ASDs, it can
861still be very useful to dissect neuronal events leading to
862these conditions (Table 3).
863Mutations in genes encoding neuroligin, neurexin, and
864shank proteins alter synaptic function and have been
865reported to underpin ID and ASDs [182–186]. Neuroligins
866are postsynaptic cell adhesion proteins that bind specifically
867to presynaptic proteins called neurexins (Fig. 3a). Both are
868present in excitatory and inhibitory synapses and are crucial
869for correct neuronal network formation and synapse
870maturation, stability, and transmission. C. elegans nrx-1
871and nlg-1 genes are orthologous to human NRXN1 and
872NLGN1 genes, respectively, with the corresponding proteins
873presenting similar functional domains [187, 188]. NGL-1 is
874expressed in a subset of neurons, and neuroligin-deficient
875mutants are viable, with no overt phenotype. However, these
876animals are defective in a subset of sensory behaviors and
877sensory processing and are hypersensitive to oxidative stress
878and mercury compounds [188–190]. Difficulties with pro-
879cessing and/or integration of sensory inputs are often part of
880the presentation of ASDs, though no sensory deficits have
881been recognized officially [191]. In this context, it is partic-
882ularly interesting that nlg-1 mutants have deficits in the
883processing of conflicting sensory inputs, as measured in an
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884 approach–avoidance paradigm. nlg-1 mutants respond nor-
885 mally to the volatile attractant diacetyl and the repellent
886 cupric acetate; however, their response to simultaneous pre-
887 sentation of these two cues is clearly defective [190].
888In further support of a similar role of mammalian and
889nematode proteins were the results showing that expression
890of human or rat neuroligin in nlg-1 mutants rescues
891osmotic avoidance and gentle touch response phenotypes.
t3:1 Table 3 Intellectual disability (ID)-related genes. Studies in C. elegans that added important value to our understanding of the function and
malfunction of human genes associated with ID
t3:2 Gene Function C. elegans findings Disease association
t3:3 ASPM Asp (abnormal spindle) homolog; may
play a role in mitotic spindle regulation
and coordination of mitosis
ASPM-1 binds to LIN-15 and is required
for its correct localization in the spindle
poles. aspm-1 mutants present
pleiotropic phenotypes suggesting that
this gene is required for other cell types
besides neurons [229]
Associated with autosomal recessive
primary microcephaly [227]
t3:4 PHF8 Histone lysine demethylase; plays a key
role in cell cycle progression, DNA
transcription, and brain development
F29B9.2 has a similar function as the
human counterpart and its knockdown
leads to uncoordination [238]
Associated with X-linked ID and cleft
lip/palate [235]
t3:5 ARX Aristaless-related homeobox;
transcription factor required for normal
brain development and maintenance of
specific neuronal subtypes in the
cerebral cortex
alr-1 mutants present deficits in the
differentiation of a GABAergic neuron;
alr-1 acts through LIM1 homolog lin-
11 pathway. It controls the expression
of target genes such as mec-3 to ensure
touch receptor neuron differentiation
[240, 289, 290]
Associated with epilepsy and ID [239]
t3:6 TUBA1A Tubulin A; major constituent of
microtubules; crucial for microtubule
formation and organization
tba-1 mutants are viable: compensatory
mechanism, since this mutation is lethal
in combination with other tubulin gene
mutations. Animals display neuronal
synaptic deficits and axonal
misguidance [242]
Associated with lissencephaly and
polymicrogyria [173, 241]
t3:7 DOPEY2 May be involved in protein traffic
between late Golgi and early
endosomes
pad-1 suppression showed embryonic
lethality.Most of the tissues of the embryo
failed to undergo proper patterning during
gastrulation; incomplete morphogenesis
did not occur [244]
Present in the Down syndrome critical
region [243]
t3:8 DYRK1A Dual-specificity tyrosine (Y)
phosphorylation-regulated kinase 1A;
suggested role in signaling pathways
regulating cell proliferation and
eventually brain development
mbk-1 nulls are viable, contrary to
mammals. However, overexpression of
this gene leads to dose-dependent
olfactory defects [250]. These defects
were reverted by normalizing mbk-1
expression, highlighting a possible
therapeutic possibility
Present in the Down syndrome critical
region [243]. Clinical trials with the
aim of normalizing DYRK1A function
are underway
t3:9 DSCR1/RCAN1 Regulator of calcineurin 1; inhibits
calcineurin-dependent transcription by
binding to the catalytic domain of
calcineurin A. Could play a role during
central nervous system development
RCN-1 has a similar function as the human
counterpart. rcn-1 deletion or
overexpression leads to similar
phenotype, including defects in growth,
fertility, cuticle development, and egg
laying. Importantly, normalization of rcn-
1 expression rescues the deficits [258]
Present in the Down syndrome critical
region [243]
t3:10 PQBP1 Polyglutamine-binding protein 1;
activation of transcription directly or
via association with the transcription
machinery
pqbp-1.1 is necessary for lipid
metabolism. No major neuronal
phenotype [262]
Mutations in this gene have been found in
patients with Renpenning's syndrome 1
and other syndromes with X-linked
mental retardation [260, 261]. Patients
present a lean body, which can be related
to worm alterations in lipid metabolism
t3:11 ATRX Alpha-thalassemia/mental retardation
syndrome X-linked; contains an
ATPase/helicase domain; SWI/SNF
family of chromatin-remodeling
proteins. Potential involvement in the
gene regulation at interphase and
chromosomal segregation in mitosis
No report regarding xnp-1 mutant
neurological phenotype. xnp-1 is vital
for gonadal development [267, 268]
Associated with alpha-thalassemia/
mental retardation syndrome X-linked
[264–266]. Patients present gonadal
abnormalities, similar to worm mutant
strains
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892 Remarkably, expression of mutant human proteins (with
893 previously identified mutations in ASDs patients) did not
894 revert behavioral impairments nor did expression of wild
895 type NGL-1 under the control of muscular promoter [188],
896 suggesting a key role for this protein in neuronal function.
897 One unexpected result in C. elegans was the fact that loss
898 of neuroligin was not merely correlated with increased sen-
899 sitivity to oxidative stress but actually caused oxidative
900 stress [190]. Though there is no concluding evidence that
901 oxidative stress may be involved in neurobiology of ASDs,
902 some recent evidence shows that autistic patients present a
903 significant elevation in oxidative stress biomarkers and re-
904 duced serum antioxidants such as transferrin and ceruloplas-
905 min [192]. C. elegans NRX-1, ortholog of neurexin, is
906 expressed in most of the neurons and localizes to presynaptic
907 specializations [193]. Contrary to ngl-1 mutants, nrx-1 nulls
908 do not present any major phenotype or deficits in osmotic
909 avoidance, but interestingly, mutations in this gene suppress
910 neuroligin deficits [187].
911 The shank gene family encodes postsynaptic proteins that
912 function as part of the NMDA receptor-associated PSD-95
913 complex (Fig. 3a) [194]. In mammals, Shank cooperates
914 with Homer protein to induce accumulation of inositol-
915 1,4,5-trisphosphate (IP3) receptors in dendritic spines and
916 formation of putative multisynapse spines [195]. Recently,
917 mutations in Shank genes have been implicated in ASDs
918 [185], suggesting an important role in normal cognitive
919 development. Overexpression of Shank1B and Homer1b in
920 hippocampal neurons induces spine maturation, including
921 translocation of the intracellular Ca2+ channel inositol tris-
922 phosphate receptor (IP3R) [196]. The nematode shn-1 gene
923 is the ortholog of vertebrate Shank1. RNAi of shn-1 did not
924 cause lethality or major developmental abnormalities. How-
925 ever and in the same line of evidence of mammalian data,
926 suppression of shn-1 in a defective IP3R background
927 resulted in animals with altered defecation rhythm [197],
928 suggesting a possible role of this protein in affecting func-
929 tion of IP3R. Additional characterization of two different
930 mutant alleles for shn-1 revealed a crucial role for the ANK-
931 repeat domain in Ca2+ signaling with IP3R [198]. It would
932 be interesting to analyze these strains regarding Ca+ signal-
933 ing and size and strength of synapses considering the fact
934 that Shank1 knockout mice present reduced size of dendritic
935 spines and weaker basal synaptic transmission [199].
936 Neurobeachin (NBEA) has been identified as an autism
937 candidate gene in a patient with a de novo chromosomal
938 translocation [200]. This multidomain scaffolding protein
939 has been suggested to be involved in neuronal post-Golgi
940 membrane traffic with a role in neurotransmitter release and
941 synaptic functioning [201–203]. Cellular knockdown of
942 NBEA suggested that this protein is a negative regulator of
943 secretion of large dense-core vesicles [203]. Study of the C.
944 elegans ortholog, sel-2, further supported this role in vesicle
945transport. Sel-2 was identified as a negative regulator of
946LIN-12/Notch activity [204], and members of the Notch
947pathway have also been shown to be modifiers of the NBEA
948homolog in Drosophila [205]. Deeper analysis of this inter-
949action may contribute to better understanding of molecular
950events leading to a subset of ASDs due to deficits in vesicle
951formation.
952L1CAMs are transmembranar cell adhesion receptors
953belonging to the immunoglobulin superfamily and are con-
954served in C. elegans. The mammalian L1CAM family is
955composed of four proteins: L1, CHL1, NrCAM, and
956neurofascin [206]. Mutations in L1 can originate the X-
957linked neurological disorder, corpus callosum hypoplasia
958(CRASH, mental retardation, adducted thumbs, spastic
959paraplegia, and hydrocephalus) [207–209]. Latest evidence
960implicated a protein of this family, NrCAM, in autism [210].
961C. elegans has two L1CAM homologs, lad-2 and lad-1 (or
962sax-7) [211–214], which have distinct biological roles.
963While lad-2 expression is restricted to a few neurons, sax-
9647 is widely expressed since embryonic stages [212, 213,
965215]. LAD-2 is important for axon migration by anchoring
966MAB-20 (ortolog of semaphorin 2) to PLX-2 (ortolog of
967plexin) [215]. Concordantly, mammalian proteins also func-
968tion as coreceptors for semaphorin-mediated axon pathfind-
969ing [216–218]. Despite involvement in the same pathway,
970lad-2 mutants have significantly more axonal defects than
971mab-20 or plx-2 mutants [215], suggesting that lad-2 may
972mediate axonal migration through another independent
973pathway, which could be interesting to ascertain in mam-
974mals. On the other hand, sax-7 mutants present a “normal”
975development of the nervous system but display deficits in
976neuronal positioning [211–214], similarly to what is ob-
977served in L1 and CHL1 knockout mice [216, 218–221]. It
978is important to refer that L1CAMs are essential in mammals
979and flies but not in worms, providing a unique framework
980for the study of the biological role of these proteins.
981Contrary to what was initially assumed, C. elegans ex-
982hibit a broad variety of social behaviors, including mutual
983attraction and aggregation, mating, population density sens-
984ing, and solitary- vs. group-feeding strategies. Variation in
985feeding strategy is solely due to a single amino acid substi-
986tution in NPY receptor, npr-1 [72]. Solitary strains present
987high npr-1 activity, whereas social strains display low ac-
988tivity. This receptor is particularly expressed in the RMG
989inter/motor neuron, the hub of a finely tuned pathway that
990controls aggregation and related behaviors [222]. No reports
991have directly implicated NPY receptors in ASDs, yet, there
992are some data that may corroborate this hypothesis. First,
993Drosophila NPY (dNFP) is involved in regulation of larval
994foraging and social behavior [223]. Second, NPY Y2
995receptor-deficient male mice display an increase in social
996interaction [224]. Third, although not conclusive since sev-
997eral genes are within the affected region, there is at least one
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998 reported case of an autistic child with a deletion leading to
999 hemizygosity for genes encoding neuropeptide receptors
1000 NPY1R and NPY5R and for glutamine and glycine
1001 neurotransmitter receptor subunits (AMPA-2, GLRA3, and
1002 GLRB) [225]. Overall, these results seem to pinpoint NPY
1003 as an important modulator of social behavior in higher
1004 species as well, though more studies need to be performed
1005 to validate this theory.
1006 Memory and Learning in C. elegans: Insights
1007 into Intellectual Disability
1008 ID is one of the most frequent neurological impairments and
1009 is a very heterogeneous group of disorders. Increasing num-
1010 ber of genes identified over the last years associated with ID
1011 suggests that this phenotype can emerge as the final common
1012 pathway ofmany different types of abnormal cellular processes.
1013 Overall, it is considered that ID can stem from two broad
1014 mechanistic themes: dysfunction of neurodevelopmental pro-
1015 grams and alterations in synaptic organization and plasticity
1016 [226], both including cellular processes and molecular players
1017 present in C. elegans (Table 4).
1018 Autosomal recessive primary microcephaly (MCPH) is
1019 characterized by a severe ID and is known to be associated
1020 with mutations in several genes, among which is the ASPM
1021 [227]. In MCPH patient cells, ASPM has been shown to be
1022 required for correct organization and orientation of the mi-
1023 totic spindle and cytokinesis [228]. The C. elegans ortholog
1024 of this protein is ASPM-1, which binds to LIN-5 and is
1025 required for correct location of LIN-5 to meiotic and mitotic
1026 spindle poles [229]. LIN-5 is the ortholog of human NuMA
1027 and belongs to the conserved pathway controlling spindle
1028 position [230]. Large-scale C. elegans RNAi experiments
1029 also indicate that aspm-1 is necessary for embryonic and
1030 larval viability, germline maintenance, vulval morphogene-
1031 sis, and locomotion [231–233], which may indicate that
1032 ASPM may be relevant for other types of cells. Indeed, very
1033 recent work showed that lack of functional ASPM was
1034 associated with loss of germ cells, both in testis and
1035 ovaries [234].
1036 The PHF8 gene, which encodes a histone demethylase,
1037 has been found to be mutated in several patients with X-
1038 linked ID and cleft lip/palate [235, 236]. The zebrafish
1039 ortholog has been shown to regulate cell survival in the
1040 developing brain and to be involved in jaw development
1041 [237]. In C. elegans, the most closely related homolog is
1042 F29B9.2, which is expressed mainly in neuronal cells. Such
1043 as the human counterpart, F29B9.2 catalyzes demethylation
1044 of di- and monomethylated lysine 9 of histone H3 in vivo.
1045 F29B9.2 inactivation leads to a relatively mild phenotype
1046 in the form of uncoordinated locomotion [238], and
1047 reexpression of the gene in mutant background under a
1048pan-neuronal promoter, but not under a muscle promoter,
1049rescued the phenotype associated with loss of F29B9.2.
1050The aristaless-related homeodomain protein ARX has
1051been shown to underlie multiple forms of X-linked ID
1052[239]. Arx knockout mice exhibit thinner cerebral cortices
1053because of decreased neural precursor proliferation and
1054also exhibit defects in differentiation and migration of
1055GABAergic interneurons [169]. C. elegans ortholog, alr-1,
1056acts in a pathway with the LIM1 ortholog lin-11 to regulate
1057development of a subset of chemosensory neurons. More-
1058over, alr-1 mutants present deficits in differentiation of a
1059GABAergic motoneuron, suggesting parallels with ARX
1060functions in vertebrates [240].
1061Mutations in TUBA1A gene have been associated with
1062cortical dysgenesis such as lissencephaly and bilateral asym-
1063metrical polymicrogyria [173, 241]. In C. elegans, null
1064alleles of the orthologous gene, tba-1, do not present any
1065major locomotor or neuronal defect, probably due to com-
1066pensatory mechanisms, since this mutation is lethal in com-
1067bination with other tubulin mutations [242]. However,
1068interestingly, a gain-of-function mutation in tba-1 leads to
1069motor neuron synapse disruption and axonal defects
1070[242], which is concordant with a role of this gene in
1071the correct development of the nervous system. Analogously,
1072(putatively) dominant mutations in human TUBA1A are
1073associated with neuronal migration deficits and axonal
1074malformation [170, 173].
1075Down syndrome is the most common form of ID world-
1076wide, caused by a triplication of all or just a critical region of
1077chromosome 21, which leads to a very specific and well-
1078defined phenotype. C21ORF5/DOPEY2 is one of the genes
1079within the “Down Syndrome Critical Region,” which are
1080hypothesized to be responsible for majority of the pheno-
1081type [243]. Of notice, the first attempt to study Down
1082syndrome-associated genes in C. elegans involved the
1083DOPEY2 ortholog pad-1 [244]. Pad-1 was found to be
1084necessary for proper patterning during gastrulation and mor-
1085phogenesis. In the same line of evidence, overexpression of
1086human DOPEY2 in mice leads to alterations in cortical
1087layers together with behavioral impairment [245, 246].
1088Another gene putatively involved in Down syndrome is
1089DYRK1A, a member of the dual-specificity tyrosine
1090phosphorylation-regulated kinase [247]. DYRK1A involve-
1091ment in critical neuronal processes such as neurogenesis and
1092neuronal differentiation has been widely studied using mice
1093but also simpler organisms such as Drosophila and C.
1094elegans [248, 249]. The C. elegans ortholog is mbk-1, but
1095in contrast to vertebrate DYRK1A orthologs and the fly
1096minibrain ortholog, lack of mbk-1 does not lead to any
1097neuronal proliferation defects [250]. However, increased
1098mbk-1 expression was shown to lead to dose-sensible spe-
1099cific functional olfactory defects. Remarkably, these defects
1100were reversible by normalizing mbk-1 expression [250],
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1101 which provided the first hint that DYRK1 induced deficits
1102 could be reversed in fully differentiated neurons. This
1103 possibility has been confirmed later in higher model
1104 organisms [251–253] and has set off several therapeutic
1105 approaches that are now being evaluated in human
1106 clinical trials (ClinicalTrials.gov identifier: NCT01394796;
1107 NCT01699711).
1108 DSCR1 is another gene residing in the Down Syndrome
1109 Critical Region [254]. DSCR1 is a known inhibitor of
1110 calcineurin-mediated signaling pathways [255], which are
1111 involved in multiple processes including neuronal plasticity
1112 [256] and neuronal development via NFAT signaling [257].
1113 DSCR1, along with DYRK1A, is thought to downregulate
1114NFAT-mediated gene activation [247]. Calcineurin regula-
1115tors seem to be evolutionarily conserved, and C. elegans
1116possesses a sole DSCR1 homolog, rcn-1 [254, 258]. Anal-
1117ogous to DSCR1, rcn-1 also inhibits calcineurin phosphatase
1118activity via calcineurin A interaction. Moreover, worms
1119overexpressing rcn-1 could reproduce multiple phenotypes
1120of calcineurin loss-of-function mutants [258] providing an
1121in vivo proof of rcn-1/calcineurin regulation and giving
1122further support as to the relation between DSCR1 overdos-
1123age and the phenotypes observed in DS.
1124Often, simple organisms do not replicate the complete
1125phenotype spectra of human disorders. Still, they may allow
1126studying and focusing on specific pathological features and
t4:1 Table 4 Autism spectrum disorder (ASD)-related genes. Studies in C. elegans that added important value to our understanding of the function and
malfunction of human genes associated with ASDs
t4:2 Gene Function C. elegans findings Disease association
t4:3 Neuroligins
NLGN3 NLGN4
Neuroligin family; cell adhesion
molecules present at the postsynaptic
side of the synapse and may be
essential for the formation of
functional synapses
nlg-1 mutants have sensory processing
deficits; hypersensitive to oxidative
stress and mercury. These animals also
present osmotic avoidance deficits and
touch response phenotype [188, 190].
Recent evidence suggests that nlg-1 and
nrx-1 mediate a retrograde synaptic
signal that inhibits neurotransmitter
release at NMJ
Mutations in these genes have been
associated with ASDs [182–184]
t4:4 Neurexins NRX1
NRX2 NRX3
Bind neuroligins and form complex that
is required for efficient
neurotransmission; involved in the
formation of synaptic contacts
nrx-1 mutants do not present observable
phenotype; however, mutations in this
gene suppress neuroligin mutations
[187]
Mutations in neurexin genes have been
associated with ASDs [186]
t4:5 SHANK1 Adapter protein in the postsynaptic
density (PSD) of excitatory synapses;
interconnects receptors including
NMDA-type and metabotropic
glutamate receptors via complexes
with PSD-95 and Homer. Plays a role
in the structural and functional
organizations of the dendritic spine
and synaptic junction
shn-1 strain presents no overt phenotype;
however, suppression of shn-1 in a
defective inositol-1,4,5-trisphosphate
(IP3) receptor background alters
defecation rhythm [197]. A key role for
ANK repeat domain and PDZ in
regulating Ca2+-signaling with the IP3
receptor [198]
Mutations in SHANK have been
associated with ASDs [185]
t4:6 NBEA Neurobeachin; binds to type II regulatory
subunits of protein kinase A and
anchors/targets them to the membrane
sel-2 is a negative regulator of LIN-12/
Notch activity; involved in vesicle
secretion (?) [204]
Mutations associated with autism [200]
t4:7 L1CAM Transmembrane cell adhesion molecule
with an important role in the
development of the nervous system;
involved in neuron–neuron adhesion,
neurite fasciculation, and outgrowth
of neurites
LAD-2 is required for axonal migration,
since it anchors MAB-20 (semaphorin)
to PLX-2 (plexin) [215]. lad-2 mutants
present severe axonal defects, which
can partially be independent on the
sempahorin/plexin pathway.
Mutations associated with CRASH
[207–209]
t4:8 lad-1 (sax-7) strain presents pleiotropic
phenotypes that include
uncoordination, embryonic lethality,
and deficits in neuronal positioning and
axonal-misguided trajectories [212]
t4:9 NPY1R NPY2R Neuropeptide Y receptor; family of Gi/
o-protein-coupled receptors that
mediate food intake, anxiety and
stress response, and control of
pituitary hormone release
Activity of npr-1 is correlated with the
degree of “socialization” [72, 291,
292]. Social and solitary strains differ
naturally in the levels of NPR-1 protein
No information about its association with
human neurodevelopmental disorders.
Yet, Drosophila NPY is involved in
social behavior as well [223], and
NPY2 receptor knockout mice present
social abnormalities [224]
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1127 better understanding of protein function. This is the case of
1128 PQBP1 gene that when mutated is associated with a com-
1129 plex X-linked disorder, Renpenning's syndrome [259–261],
1130 characterized by ID and lean body build (OMIM #309500).
1131 The C. elegans ortholog is pqbp-1.1 that, such as the human
1132 counterpart, encodes a protein with a polyglutamine-binding
1133 region in polar amino acid-rich domain, a WW domain
1134 also involved in regulation of transcription activity, and
1135 a C-terminal domain involved in the interaction with a
1136 spliceosome component [262]. Although pqbp-1.1 is
1137 expressed in few neurons, no neuronal phenotype was ob-
1138 served in pqbp-1.1-functional mutants. However, it was
1139 observed that lack of pqbp-1.1 leads to alterations in lipid
1140 metabolism shown by a reduction of triglycerides [262],
1141 which could be somehow related to lean body observed in
1142 human patients. Considering that the lipidic metabolic path-
1143 ways are fundamentally conserved between species, C.
1144 elegans could be a good model to study PQBP1-induced
1145 lipidic dysfunction and its effects in neurons.
1146 Another example is the ATRX gene, which is associated
1147 with a complex X-linked ID syndrome, alpha-thalassemia
1148 mental retardation, X linked [263]. Patients exhibit severe
1149 ID and genital abnormalities, among other clinical features
1150 (reviewed in [264]). The ATRX gene encodes a member of a
1151 transcription regulator family of proteins, Swi2/Snf2 [265].
1152 In mice, ATRX is suggested to interact with MeCP2 and
1153 cohesin (also involved in ID) to regulate gene expression
1154 during brain development [266]. Worm ortholog is xnp-1,
1155 and although no neurological phenotype has been reported,
1156 xnp-1 has been shown to be required for correct embryo-
1157 genesis. In parallel with what has been observed in humans,
1158 xnp-1 is also necessary for normal gonad development [267,
1159 268]. As at least the gonad development-related function of
1160 xnp-1/ATRX seems to be conserved, C. elegans could be a
1161 good model to identify additional interacting partners and
1162 developmental signaling pathways involved in the disorder
1163 and perhaps phenotype-modifying compounds.
1164 Insights on Other Neurodevelopmental Disorders
1165 Disrupted-in-Schizophrenia 1 (DISC1) is a very well-
1166 established susceptibility gene for schizophrenia that also
1167 seems to be involved in other disorders such as ASD,
1168 depression, and bipolar disorder [269]. DISC1 protein has
1169 been thoroughly studied and is known to act as a scaffold
1170 protein, with multiple and diverse interacting partners, in-
1171 volved in neurodevelopmental and neurosignaling processes
1172 [270]. The C. elegans genome does not contain a DISC1
1173 ortholog. However, a heterologous strain expressing
1174 mDISC1 was useful to dissect the pathway by which DISC1
1175 may regulate axonal connections. Studies using this
1176 model showed that in motor neurons, DISC1 interacts
1177with UNC-73/TRIO and activates RAC–PAK signaling
1178to regulate axon guidance [271]. Interestingly, these
1179pathways are conserved, and in mammals, it is known
1180that TRIO regulates axon growth and guidance via RAC
1181[272]. Furthermore, this heterologous C. elegans model
1182may represent a good tool to identify new small molecules
1183with therapeutic effects in modulating the TRIO–RAC
1184pathway such as those that regulate axonal connectivity.
1185From Genes to Therapies
1186C. elegans represents a powerful tool to dissect cellular and
1187molecular processes of human disorders and has emerged as
1188an attractive platform in the context of large drug or genetic
1189screenings due to its simplicity, low cost of cultivation, and
1190small size that allows their growth on microtiter plates.
1191Moreover, ease of genetic manipulation and commonality
1192of several biological processes are both valuable in the gene-
1193to-drug and drug-to-gene discovery (nicely reviewed in
1194[53]). If on one side, random mutagenesis can help in
1195identification of novel gene targets conferring susceptibility
1196or resistance to a specific group of drugs, large-scale drug
1197screenings in specific genetic backgrounds may help dissect
1198the mechanisms of drug action in normal and pathological
1199conditions.
1200An elegant example is the identification of 185 aldicarb-
1201resistant mutants, among which were 132 genes that had not
1202be previously associated with synaptic transmission. Of
1203these, 24 encoded proteins that were localized to presynaptic
1204specializations, and loss-of-function mutations in 12 genes
1205caused defects in presynaptic structure [22].
1206Others have used transgenic worm models expressing the
1207mutated human protein to perform both genetic and drug
1208screenings. For example, Kraemer's lab has used a worm
1209model of tauopathy to screen a drug library containing 1,120
1210molecules. They identified azaperone, a typical antipsychotic
1211drug, as a robust modifier of motor deficits and levels of
1212insoluble tau [128]. Suggesting common drug-acting path-
1213ways in worms and humans, azaperone was also effective in
1214reducing tau aggregation in a human cell line. Remarkably,
1215other drugs acting on dopamine receptor D2 such as
1216flupenthixol, perphenazine, and zotepine were also effective
1217in ameliorating tau-induced dysfunction in both models,
1218suggesting D2 antagonism as a promising therapeutic strategy
1219for tau neurotoxicity [128], a pathway that without C. elegans
1220contribution would be unlikely to be discovered.
1221In another study, four different chemical libraries com-
1222prising 14,100 small membrane-permeable compounds
1223were screened for induction of behavioral/morphological
1224defects in wild type worms [273]. Three hundred eight
1225molecules led to a variety of phenotypes, from simple mo-
1226tility deficits to severe morphological problems. However,
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1227 despite this high-hit result for bioactivity of new drugs in C.
1228 elegans, an important consideration is the gap between
1229 worm and human mechanisms of drug absorption, distribu-
1230 tion, metabolism, excretion, or toxicity. Nevertheless, in this
1231 screen, researchers also discovered that a novel compound,
1232 which they named nemadipine-A, resembling a class of
1233 antihypertension drugs called the 1,4-dihydropyridines that
1234 antagonize the alpha 1-subunit of L-type calcium channels,
1235 induced robust defects in morphology and egg laying. They
1236 identified egl-19, the only L-type calcium channel alpha 1-
1237 subunit in C. elegans, as the target gene in a genetic sup-
1238 pressor screening. Interestingly, the compound could also
1239 antagonize vertebrate L-type calcium channels, demonstrating
1240 that worms and mammals share a common target, despite
1241 originating divergent phenotypical outcomes.
1242 Another example is the “hypothesis-free approach”
1243 screening of 900,000 small molecules that allowed identifi-
1244 cation of new classes of proteostasis regulators important in
1245 treatment of several conformational diseases such as
1246 polyglutamine disorders and Alzheimer's and Parkinson's
1247 diseases. Though some of these molecules acted via
1248 “canonical pathways” such as via HSF-1, FOXO, and
1249 NRF-2 and the chaperone machinery, the underlying mech-
1250 anisms were distinct from previously identified small-
1251 molecule activators of the heat shock response [274].
1252 Not much has been done in the context of neuro-
1253 developmental disorders regarding large-scale genetic
1254 and/or drug screening approaches. Several factors may
1255 contribute to this: first, neurodevelopmental disorders
1256 frequently encompass complex and difficult “scorable” phe-
1257 notypes (e.g., neuronal migration defects or abnormal
1258 synaptic transmission) that restrain large-scale analysis
1259 methodology. Second, for several neurodevelopmental dis-
1260 orders, there is no unique drug or gene that modifies the
1261 phenotype satisfactorily due to their inherent complexity.
1262 Nevertheless, considering all pros and cons of using C.
1263 elegans in this type of screenings, we still believe that the
1264 strategy of using this model as the first line of research may
1265 lead to identification of novel and implausible drugs and/or
1266 cellular/molecular pathways of drug action that otherwise
1267 would be difficult to pinpoint. Yet, once a drug (gene?) is
1268 identified as potentially relevant in the context of a specific
1269 disorder in worms, additional studies need to be performed
1270 in higher organisms to fully validate it and exclude all side
1271 effects that it may have in the context of a more complex
1272 organism.
1273 Final Remarks
1274 The transparent worm C. elegans is one of the most power-
1275 ful and versatile model organisms, enabling elucidation of
1276 several cellular and molecular mechanisms underlying
1277neuronal function and dysfunction. Due to easiness of ge-
1278netic manipulation and similarity with vertebrate neuronal
1279molecular pathways, this organism can be used to functionally
1280validate genetic associations identified in neurodevelopmental
1281disorders. Moreover, since C. elegans is amenable to high-
1282throughput genetic and drug screenings, it is an excellent
1283biological platform for drug identification and clarifica-
1284tion of signaling pathways involved in novel therapeutic
1285interventions.
1286
1287Acknowledgments The authors would like to acknowledge
1288Fundaçãopara a Ciência e Tecnologia (FCT) (PTDC/SAU-GMG/
1289112577/2009). CB is a recipient of a postdoctoral fellowship from FCT.
1290
1291References Q11292
12931. Bessa, C.L., F; Maciel, P, Molecular genetics of intellectual
1294disability, InTech, Editor 2012
12952. Abrams TW (2012) Studies on aplysia neurons suggest treatments
1296for chronic human disorders. Curr Biol 22(17):R705–11
12973. Gatto CL, Broadie K (2011) Drosophila modeling of heritable
1298neurodevelopmental disorders. Curr Opin Neurobiol 21(6):834–
129941
13004. Kabashi E et al (2010) In the swim of things: recent insights to
1301neurogenetic disorders from zebrafish. Trends Genet 26(8):373–
130281
13035. Wormbook. Available from: http://www.wormbook.org/
13046. Wormatlas. Available from: http://www.wormatlas.org/
13057. Bono MD, Villu Maricq A (2005) Neuronal substrates of com-
1306plex behaviors in C. elegans. Annu Rev Neurosci 28(1):451–501
13078. Chalfie M et al (1994) Green fluorescent protein as a marker for
1308gene expression. Science 263(5148):802–5
13099. Hobert O, Loria P (2006) Uses of GFP in Caenorhabditis
1310elegans. Methods Biochem Anal 47:203–26
131110. White JG et al (1986) The structure of the nervous system of the
1312nematode Caenorhabditis elegans. Philos Trans R Soc Lond B
1313Biol Sci 314(1165):1–340
131411. Jin, Y., Synaptogenesis. WormBook, 2005: p. 1–11
131512. Nonet ML (1999) Visualization of synaptic specializations in live
1316C. elegans with synaptic vesicle protein–GFP fusions. J Neurosci
1317Methods 89(1):33–40
131813. Dittman JS, Kaplan JM (2006) Factors regulating the abundance
1319and localization of synaptobrevin in the plasma membrane. Proc
1320Natl Acad Sci USA 103(30):11399–404
132114. Jin Yet al (1999) TheCaenorhabditis elegans gene unc-25 encodes
1322glutamic acid decarboxylase and is required for synaptic transmis-
1323sion but not synaptic development. J Neurosci 19(2):539–48
132415. Vashlishan AB et al (2008) An RNAi screen identifies genes that
1325regulate GABA synapses. Neuron 58(3):346–361
132616. Zhen M, Jin Y (1999) The liprin protein SYD-2 regulates the
1327differentiation of presynaptic termini in C. elegans. Nature
1328401(6751):371–5
132917. Yeh E et al (2005) Identification of genes involved in
1330synaptogenesis using a fluorescent active zone marker in
1331Caenorhabditis elegans. J Neurosci 25(15):3833–41
133218. Stigloher C et al (2011) The presynaptic dense projection of the
1333Caenorhabditis elegans cholinergic neuromuscular junction
1334localizes synaptic vesicles at the active zone through SYD-
13352/liprin and UNC-10/RIM-dependent interactions. J Neurosci
133631(12):4388–96
Mol Neurobiol
JrnlID 12035_ArtID 8434_Proof# 1 - 05/03/2013
AUTHOR'S PROOF
U
N
C
O
R
R
EC
TE
D
PR
O
O
F
1337 19. Hall DH, Russell RL (1991) The posterior nervous system of the
1338 nematode Caenorhabditis elegans: serial reconstruction of
1339 identified neurons and complete pattern of synaptic interactions. J
1340 Neurosci 11(1):1–22
1341 20. Zhao H, Nonet ML (2000) A retrograde signal is involved in
1342 activity-dependent remodeling at a C. elegans neuromuscular
1343 junction. Development 127(6):1253–66
1344 21. Rand, J.B., Acetylcholine. WormBook, 2007: p. 1–21
1345 22. Sieburth D et al (2005) Systematic analysis of genes required for
1346 synapse structure and function. Nature 436(7050):510–7
1347 23. Brockie PJ et al (2001) Differential expression of glutamate
1348 receptor subunits in the nervous system of Caenorhabditis
1349 elegans and their regulation by the homeodomain protein UNC-
1350 42. J Neurosci 21(5):1510–22
1351 24. Brockie, P.J. and A.V. Maricq, Ionotropic glutamate receptors:
1352 genetics, behavior and electrophysiology. WormBook, 2006:
1353 p. 1–16
1354 25. Brockie PJ, Maricq AV (2003) Ionotropic glutamate receptors in
1355 Caenorhabditis elegans. Neurosignals 12(3):108–25
1356 26. Cully DF et al (1994) Cloning of an avermectin-sensitive
1357 glutamate-gated chloride channel from Caenorhabditis elegans.
1358 Nature 371(6499):707–11
1359 27. Avery L (1993) The genetics of feeding in Caenorhabditis
1360 elegans. Genetics 133(4):897–917
1361 28. Lee RY et al (1999) EAT-4, a homolog of a mammalian sodium-
1362 dependent inorganic phosphate cotransporter, is necessary for
1363 glutamatergic neurotransmission in Caenorhabditis elegans. J
1364 Neurosci 19(1):159–67
1365 29. Rankin CH, Wicks SR (2000) Mutations of the Caenorhabditis
1366 elegans brain-specific inorganic phosphate transporter eat-4
1367 affect habituation of the tap-withdrawal response without
1368 affecting the response itself. J Neurosci 20(11):4337–44
1369 30. Rose JK, Kaun KR, Rankin CH (2002) A new group-training
1370 procedure for habituation demonstrates that presynaptic gluta-
1371 mate release contributes to long-term memory in Caenorhabditis
1372 elegans. Learn Mem 9(3):130–7
1373 31. Lee D et al (2008) Human vesicular glutamate transporters func-
1374 tionally complement EAT-4 in C. elegans. Mol Cells 25(1):50–4
1375 32. Morrison GE, van der Kooy D (2001) A mutation in the AMPA-
1376 type glutamate receptor, glr-1, blocks olfactory associative and
1377 nonassociative learning in Caenorhabditis elegans. Behav
1378 Neurosci 115(3):640–9
1379 33. Chase, D.L. and M.R. Koelle, Biogenic amine neurotransmitters
1380 in C. elegans. WormBook, 2007: p. 1–15
1381 34. Chase DL, Pepper JS, Koelle MR (2004) Mechanism of
1382 extrasynaptic dopamine signaling in Caenorhabditis elegans.
1383 Nat Neurosci 7(10):1096–103
1384 35. Cao S et al (2005) Torsin-mediated protection from cellular stress
1385 in the dopaminergic neurons of Caenorhabditis elegans. J
1386 Neurosci 25(15):3801–12
1387 36. Marvanova M, Nichols CD (2007) Identification of
1388 neuroprotective compounds of Caenorhabditis elegans dopami-
1389 nergic neurons against 6-OHDA. J Mol Neurosci 31(2):127–37
1390 37. Nass R, Blakely RD (2003) The Caenorhabditis elegans
1391 dopaminergic system: opportunities for insights into dopamine
1392 transport and neurodegeneration. Annu Rev Pharmacol Toxicol
1393 43:521–44
1394 38. Jorgensen, E.M., Gaba. WormBook, 2005: p. 1–13
1395 39. Beg AA, Jorgensen EM (2003) EXP-1 is an excitatory GABA-
1396 gated cation channel. Nat Neurosci 6(11):1145–52
1397 40. Bamber BA et al (2005) The composition of the GABA receptor
1398 at the Caenorhabditis elegans neuromuscular junction. Br J
1399 Pharmacol 144(4):502–9
1400 41. Bamber BA, Twyman RE, Jorgensen EM (2003) Pharmacologi-
1401 cal characterization of the homomeric and heteromeric UNC-49
1402 GABA receptors in C. elegans. Br J Pharmacol 138(5):883–93
140342. Schuske K, Beg AA, Jorgensen EM (2004) The GABA nervous
1404system in C. elegans. Trends Neurosci 27(7):407–14
140543. Li, C. and K. Kim, Neuropeptides. WormBook, 2008: p. 1–36
140644. Pierce SB et al (2001) Regulation of DAF-2 receptor signaling by
1407human insulin and ins-1, a member of the unusually large and
1408diverse C. elegans insulin gene family. Genes Dev 15(6):672–86
140945. Li W, Kennedy SG, Ruvkun G (2003) daf-28 encodes a C.
1410elegans insulin superfamily member that is regulated by
1411environmental cues and acts in the DAF-2 signaling pathway.
1412Genes Dev 17(7):844–58
141346. Clancy DJ et al (2001) Extension of life-span by loss of
1414CHICO, a Drosophila insulin receptor substrate protein. Science
1415292(5514):104–6
141647. Tatar M et al (2001) A mutant Drosophila insulin receptor
1417homolog that extends life-span and impairs neuroendocrine
1418function. Science 292(5514):107–10
141948. Holzenberger M et al (2003) IGF-1 receptor regulates lifespan
1420and resistance to oxidative stress in mice. Nature 421(6919):182–
14217
142249. Choy RK, Kemner JM, Thomas JH (2006) Fluoxetine-resistance
1423genes in Caenorhabditis elegans function in the intestine and
1424may act in drug transport. Genetics 172(2):885–92
142550. Choy RK, Thomas JH (1999) Fluoxetine-resistant mutants in C.
1426elegans define a novel family of transmembrane proteins. Mol
1427Cell 4(2):143–52
142851. Weinshenker D, Garriga G, Thomas JH (1995) Genetic and
1429pharmacological analysis of neurotransmitters controlling egg
1430laying in C. elegans. J Neurosci 15(10):6975–85
143152. Ward A et al (2009) Cocaine modulates locomotion behavior in
1432C. elegans. PLoS One 4(6):e5946
143353. Artal-Sanz M, de Jong L, Tavernarakis N (2006) Caenorhabditis
1434elegans: a versatile platform for drug discovery. Biotechnol J
14351(12):1405–18
143654. Culotti JG, Russell RL (1978) Osmotic avoidance defective
1437mutants of the nematode Caenorhabditis elegans. Genetics
143890(2):243–56
143955. Wheeler JM, Thomas JH (2006) Identification of a novel gene
1440family involved in osmotic stress response in Caenorhabditis
1441elegans. Genetics 174(3):1327–36
144256. Hart AC et al (1999) Distinct signaling pathways mediate touch
1443and osmosensory responses in a polymodal sensory neuron. J
1444Neurosci 19(6):1952–8
144557. Bargmann CI, Horvitz HR (1991) Chemosensory neurons with
1446overlapping functions direct chemotaxis to multiple chemicals in
1447C. elegans. Neuron 7(5):729–42
144858. Sambongi Y et al (2000) Caenorhabditis elegans senses protons
1449through amphid chemosensory neurons: proton signals elicit
1450avoidance behavior. NeuroReport 11(10):2229–32
145159. Zhang Y, Lu H, Bargmann CI (2005) Pathogenic bacteria induce
1452aversive olfactory learning in Caenorhabditis elegans. Nature
1453438(7065):179–84
145460. Apfeld J, Kenyon C (1999) Regulation of lifespan by sensory
1455perception in Caenorhabditis elegans. Nature 402(6763):804–9
145661. Libert S et al (2007) Regulation of Drosophila life span by
1457olfaction and food-derived odors. Science 315(5815):1133–7
145862. Steidl S, Rose JK, Rankin CH (2003) Stages of memory in the
1459nematode Caenorhabditis elegans. Behav Cogn Neurosci Rev
14602(1):3–14
146163. Lin, C.H. and C.H. Rankin, Nematode learning and memory:
1462neuroethology, in Encyclopedia of animal behavior, D.B.
1463Editors-in-Chief:Michael and M. Janice, Editors. 2010, Academic:
1464Oxford. p. 520–526
146564. Mohri A et al (2005) Genetic control of temperature preference in
1466the nematode Caenorhabditis elegans. Genetics 169(3):1437–50
146765. Wen JYet al (1997) Mutations that prevent associative learning in
1468C. elegans. Behav Neurosci 111(2):354–68
Mol Neurobiol
JrnlID 12035_ArtID 8434_Proof# 1 - 05/03/2013
AUTHOR'S PROOF
U
N
C
O
R
R
EC
TE
D
PR
O
O
F
1469 66. Hukema RK et al (2006) Antagonistic sensory cues generate
1470 gustatory plasticity in Caenorhabditis elegans. EMBO J
1471 25(2):312–22
1472 67. Jansen G, Weinkove D, Plasterk RH (2002) The G-protein
1473 gamma subunit gpc-1 of the nematode C. elegans is involved in
1474 taste adaptation. EMBO J 21(5):986–94
1475 68. Mori I, Ohshima Y (1995) Neural regulation of thermotaxis in
1476 Caenorhabditis elegans. Nature 376(6538):344–8
1477 69. Saeki S, Yamamoto M, Iino Y (2001) Plasticity of chemotaxis
1478 revealed by paired presentation of a chemoattractant and
1479 starvation in the nematode Caenorhabditis elegans. J Exp Biol
1480 204(Pt 10):1757–64
1481 70. Rose JK et al (2003) GLR-1, a non-NMDA glutamate receptor
1482 homolog, is critical for long-term memory in Caenorhabditis
1483 elegans. J Neurosci 23(29):9595–9
1484 71. Beck CD, Rankin CH (1997) Long-term habituation is produced
1485 by distributed training at long ISIs and not by massed training or
1486 short ISIs in Caenorhabditis elegans. Anim Learn Behav
1487 25(4):446–457
1488 72. de Bono M, Bargmann CI (1998) Natural variation in a neuro-
1489 peptide Y receptor homolog modifies social behavior and food
1490 response in C. elegans. Cell 94(5):679–689
1491 73. Lin S, Boey D, Herzog H (2004) NPY and Y receptors: lessons
1492 from transgenic and knockout models. Neuropeptides 38(4):189–
1493 200
1494 74. Thorsell A et al (2006) The effects of social isolation on neuro-
1495 peptide Y levels, exploratory and anxiety-related behaviors in
1496 rats. Pharmacol Biochem Behav 83(1):28–34
1497 75. Aydin C, Oztan O, Isgor C (2011) Effects of a selective Y2R
1498 antagonist, JNJ-31020028, on nicotine abstinence-related social
1499 anxiety-like behavior, neuropeptide Y and corticotropin releasing
1500 factor mRNA levels in the novelty-seeking phenotype. Behav
1501 Brain Res 222(2):332–41
1502 76. Timmons L, Court DL, Fire A (2001) Ingestion of bacterially
1503 expressed dsRNAs can produce specific and potent genetic
1504 interference in Caenorhabditis elegans. Gene 263(1–2):103–12
1505 77. Simmer F et al (2002) Loss of the putative RNA-directed RNA
1506 polymerase RRF-3 makes C. elegans hypersensitive to RNAi.
1507 Curr Biol 12(15):1317–9
1508 78. Esposito G et al (2007) Efficient and cell specific knock-down of
1509 gene function in targetedC. elegans neurons. Gene 395(1–2):170–6
1510 79. Tavernarakis N et al (2000) Heritable and inducible genetic
1511 interference by double-stranded RNA encoded by transgenes.
1512 Nat Genet 24(2):180–3
1513 80. Kerr R et al (2000) Optical imaging of calcium transients
1514 in neurons and pharyngeal muscle of C. elegans. Neuron
1515 26(3):583–94
1516 81. Kuhara A et al (2008) Temperature sensing by an olfactory
1517 neuron in a circuit controlling behavior of C. elegans. Science
1518 320(5877):803–7
1519 82. Nishida Yet al (2011) Identification of the AFD neuron as the site
1520 of action of the CREB protein in Caenorhabditis elegans
1521 thermotaxis. EMBO Rep 12(8):855–62
1522 83. Schafer, W.R., Neurophysiological methods in C. elegans: an
1523 introduction. WormBook, 2006: p. 1–4
1524 84. Francis MM, Mellem JE, Maricq AV (2003) Bridging the gap
1525 between genes and behavior: recent advances in the electrophys-
1526 iological analysis of neural function in Caenorhabditis elegans.
1527 Trends Neurosci 26(2):90–9
1528 85. Nonet ML et al (1998) Synaptic transmission deficits in
1529 Caenorhabditis elegans synaptobrevin mutants. J Neurosci
1530 18(1):70–80
1531 86. Dent JA, Davis MW, Avery L (1997) avr-15 encodes a chloride
1532 channel subunit that mediates inhibitory glutamatergic neuro-
1533 transmission and ivermectin sensitivity in Caenorhabditis
1534 elegans. EMBO J 16(19):5867–79
153587. NickellWTet al (2002) Single ionic channels of twoCaenorhabditis
1536elegans chemosensory neurons in native membrane. J Membr
1537Biol 189(1):55–66
153888. O'Hagan R, Chalfie M, Goodman MB (2005) The MEC-4 DEG/
1539ENaC channel of Caenorhabditis elegans touch receptor neurons
1540transduces mechanical signals. Nat Neurosci 8(1):43–50
154189. Richmond JE, Jorgensen EM (1999) One GABA and two
1542acetylcholine receptors function at the C. elegans neuromuscular
1543junction. Nat Neurosci 2(9):791–7
154490. Mellem JE et al (2002) Decoding of polymodal sensory stimuli
1545by postsynaptic glutamate receptors in C. elegans. Neuron
154636(5):933–44
154791. Goodman MB et al (1998) Active currents regulate sensitivity
1548and dynamic range in C. elegans neurons. Neuron 20(4):763–72
154992. Lockery SR, Goodman MB (1998) Tight-seal whole-cell patch
1550clamping of Caenorhabditis elegans neurons. Methods Enzymol
1551293:201–17
155293. Wicks SR, Rankin CH (1995) Integration of mechanosensory
1553stimuli in Caenorhabditis elegans. J Neurosci 15(3 Pt 2):2434–44
155494. Wicks SR, Rankin CH (1996) The integration of antagonistic
1555reflexes revealed by laser ablation of identified neurons deter-
1556mines habituation kinetics of the Caenorhabditis elegans tap
1557withdrawal response. J Comp Physiol A 179(5):675–85
155895. Chung SH et al (2006) The role of the AFD neuron in C. elegans
1559thermotaxis analyzed using femtosecond laser ablation. BMC
1560Neurosci 7:30
156196. Kimura KD et al (2004) The C. elegans thermosensory neuron
1562AFD responds to warming. Curr Biol 14(14):1291–5
156397. Chalfie M et al (1985) The neural circuit for touch sensitivity in
1564Caenorhabditis elegans. J Neurosci 5(4):956–64
156598. Harbinder S et al (1997) Genetically targeted cell disruption in
1566Caenorhabditis elegans. Proc Natl Acad Sci USA 94(24):13128–33
156799. Qi YB et al (2012) Photo-inducible cell ablation in Caenorhabditis
1568elegans using the genetically encoded singlet oxygen generating
1569protein miniSOG. Proc Natl Acad Sci USA 109(19):7499–504
1570100. Byrne, A.B., T.J. Edwards, and M. Hammarlund, In vivo laser
1571axotomy in C. elegans. J Vis Exp, 2011(51)
1572101. Hammarlund M et al (2009) Axon regeneration requires a
1573conserved MAP kinase pathway. Science 323(5915):802–6
1574102. Zhang F et al (2007) Multimodal fast optical interrogation of
1575neural circuitry. Nature 446(7136):633–9
1576103. Li W et al (2011) The neural circuits and sensory channels
1577mediating harsh touch sensation in Caenorhabditis elegans. Nat
1578Commun 2:315
1579104. Lindsay TH, Thiele TR, Lockery SR (2011) Optogenetic analysis
1580of synaptic transmission in the central nervous system of the
1581nematode Caenorhabditis elegans. Nat Commun 2:306
1582105. Liewald JF et al (2008) Optogenetic analysis of synaptic function.
1583Nat Methods 5(10):895–902
1584106. Stirman JN et al (2010) High-throughput study of synaptic trans-
1585mission at the neuromuscular junction enabled by optogenetics
1586and microfluidics. J Neurosci Methods 191(1):90–3
1587107. Leifer AM et al (2011) Optogenetic manipulation of neural
1588activity in freely moving Caenorhabditis elegans. Nat Methods
15898(2):147–52
1590108. Okazaki A, Sudo Y, Takagi S (2012) Optical silencing of C.
1591elegans cells with arch proton pump. PLoS One 7(5):e35370
1592109. Caceres Ide C et al (2012) Laterally orienting C. elegans using
1593geometry at microscale for high-throughput visual screens in
1594neurodegeneration and neuronal development studies. PLoS
1595One 7(4):e35037
1596110. Shaye DD, Greenwald I (2011) OrthoList: a compendium of C.
1597elegans genes with human orthologs. PLoS One 6(5):e20085
1598111. Kraemer BC et al (2006) Molecular pathways that influence
1599human tau-induced pathology in Caenorhabditis elegans. Hum
1600Mol Genet 15(9):1483–96
Mol Neurobiol
JrnlID 12035_ArtID 8434_Proof# 1 - 05/03/2013
AUTHOR'S PROOF
U
N
C
O
R
R
EC
TE
D
PR
O
O
F
1601 112. Kraemer BC et al (2003) Neurodegeneration and defective
1602 neurotransmission in a Caenorhabditis elegans model of
1603 tauopathy. Proc Natl Acad Sci USA 100(17):9980–5
1604 113. Levitan D et al (1996) Assessment of normal and mutant human
1605 presenilin function in Caenorhabditis elegans. Proc Natl Acad
1606 Sci USA 93(25):14940–4
1607 114. Link CD et al (2003) Gene expression analysis in a transgenic
1608 Caenorhabditis elegans Alzheimer's disease model. Neurobiol
1609 Aging 24(3):397–413
1610 115. Wittenburg N et al (2000) Presenilin is required for proper
1611 morphology and function of neurons in C. elegans. Nature
1612 406(6793):306–9
1613 116. Hamamichi S et al (2008) Hypothesis-based RNAi screening
1614 identifies neuroprotective genes in a Parkinson's disease model.
1615 Proc Natl Acad Sci USA 105(2):728–33
1616 117. Vartiainen S et al (2006) Identification of gene expression
1617 changes in transgenic C. elegans overexpressing human alpha-
1618 synuclein. Neurobiol Dis 22(3):477–86
1619 118. Teixeira-Castro A et al (2011) Neuron-specific proteotoxicity of
1620 mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1
1621 pathways. Hum Mol Genet 20(15):2996–3009
1622 119. Faber PW et al (1999) Polyglutamine-mediated dysfunction and
1623 apoptotic death of a Caenorhabditis elegans sensory neuron. Proc
1624 Natl Acad Sci USA 96(1):179–84
1625 120. Satyal SH et al (2000) Polyglutamine aggregates alter protein
1626 folding homeostasis in Caenorhabditis elegans. Proc Natl Acad
1627 Sci USA 97(11):5750–5
1628 121. Rodrigues AJ et al (2007) Functional genomics and biochemical
1629 characterization of the C. elegans orthologue of the Machado–
1630 Joseph disease protein ataxin-3. FASEB J 21(4):1126–36
1631 122. Rodrigues AJ et al (2009) ATX-3, CDC-48 and UBXN-5: a new
1632 trimolecular complex in Caenorhabditis elegans. Biochem
1633 Biophys Res Commun 386(4):575–81
1634 123. de Voer G et al (2005) Deletion of the Caenorhabditis elegans
1635 homologues of the CLN3 gene, involved in human juvenile
1636 neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.
1637 J Inherit Metab Dis 28(6):1065–80
1638 124. Oeda T et al (2001) Oxidative stress causes abnormal accumula-
1639 tion of familial amyotrophic lateral sclerosis-related mutant
1640 SOD1 in transgenic Caenorhabditis elegans. Hum Mol Genet
1641 10(19):2013–23
1642 125. Baumeister R, Ge L (2002) The worm in us—Caenorhabditis
1643 elegans as a model of human disease. Trends Biotechnol
1644 20(4):147–8
1645 126. Miyasaka T et al (2005) Progressive neurodegeneration in C.
1646 elegans model of tauopathy. Neurobiol Dis 20(2):372–83
1647 127. Fatouros C et al (2012) Inhibition of tau aggregation in a
1648 novel Caenorhabditis elegans model of tauopathy mitigates
1649 proteotoxicity. Hum Mol Genet 21(16):3587–603
1650 128. McCormick, A.V., et al., Dopamine D2 receptor antagonism sup-
1651 presses tau aggregation and neurotoxicity. Biol Psychiatry, 2012
1652 129. Guthrie CR, Schellenberg GD, Kraemer BC (2009) SUT-2
1653 potentiates tau-induced neurotoxicity in Caenorhabditis elegans.
1654 Hum Mol Genet 18(10):1825–38
1655 130. Kraemer BC, Schellenberg GD (2007) SUT-1 enables tau-induced
1656 neurotoxicity in C. elegans. Hum Mol Genet 16(16):1959–71
1657 131. Barr MM, Sternberg PW (1999) A polycystic kidney-disease
1658 gene homologue required for male mating behaviour in C.
1659 elegans. Nature 401(6751):386–9
1660 132. Igarashi P, Somlo S (2002) Genetics and pathogenesis of
1661 polycystic kidney disease. J Am Soc Nephrol 13(9):2384–98
1662 133. Lee JE, Gleeson JG (2011) Cilia in the nervous system: linking
1663 cilia function and neurodevelopmental disorders. Curr Opin
1664 Neurol 24(2):98–105
1665 134. Hirose S et al (2005) Genetics of idiopathic epilepsies. Epilepsia
1666 46(Suppl 1):38–43
1667135. Lu Y, Wang X (2009) Genes associated with idiopathic
1668epilepsies: a current overview. Neurol Res 31(2):135–43
1669136. Noebels JL (2003) Exploring new gene discoveries in idiopathic
1670generalized epilepsy. Epilepsia 44(Suppl 2):16–21
1671137. Kash SF et al (1997) Epilepsy in mice deficient in the 65-kDa
1672isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA
167394(25):14060–5
1674138. Kearney JA et al (2006) Severe epilepsy resulting from genetic
1675interaction between Scn2a and Kcnq2. Hum Mol Genet
167615(6):1043–8
1677139. Noebels JL, Sidman RL (1979) Inherited epilepsy: spike–wave
1678and focal motor seizures in the mutant mouse tottering. Science
1679204(4399):1334–6
1680140. Smart SL et al (1998) Deletion of the K(V)1.1 potassium channel
1681causes epilepsy in mice. Neuron 20(4):809–19
1682141. Zhang X et al (2010) Deletion of the potassium channel Kv12.2
1683causes hippocampal hyperexcitability and epilepsy. Nat Neurosci
168413(9):1056–8
1685142. Khosravani H, Zamponi GW (2006) Voltage-gated calcium
1686channels and idiopathic generalized epilepsies. Physiol Rev
168786(3):941–66
1688143. Williams SN et al (2004) Epileptic-like convulsions associated
1689with LIS-1 in the cytoskeletal control of neurotransmitter signal-
1690ing in Caenorhabditis elegans. Hum Mol Genet 13(18):2043–59
1691144. Nehrke K, Denton J, Mowrey W (2008) Intestinal Ca2+ wave
1692dynamics in freely moving C. elegans coordinate execution of a
1693rhythmic motor program. Am J Physiol Cell Physiol 294(1):
1694C333–44
1695145. Stawicki TM et al (2011) TRPM channels modulate epileptic-like
1696convulsions via systemic ion homeostasis. Curr Biol 21(10):883–8
1697146. Steinlein OK et al (1995) A missense mutation in the neuronal
1698nicotinic acetylcholine receptor alpha 4 subunit is associated with
1699autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet
170011(2):201–3
1701147. Monteilh-Zoller MK et al (2003) TRPM7 provides an ion channel
1702mechanism for cellular entry of trace metal ions. J Gen Physiol
1703121(1):49–60
1704148. Hsiao B, Dweck D, Luetje CW (2001) Subunit-dependent
1705modulation of neuronal nicotinic receptors by zinc. J Neurosci
170621(6):1848–56
1707149. Smart TG, Hosie AM, Miller PS (2004) Zn2+ ions: modulators of
1708excitatory and inhibitory synaptic activity. Neuroscientist
170910(5):432–42
1710150. Pandey R et al (2010) Baccoside A suppresses epileptic-like sei-
1711zure/convulsion in Caenorhabditis elegans. Seizure 19(7):439–442
1712151. Dibbens LM et al (2009) Familial and sporadic 15q13.3
1713microdeletions in idiopathic generalized epilepsy: precedent
1714for disorders with complex inheritance. Hum Mol Genet
171518(19):3626–3631
1716152. Helbig I et al (2009) 15q13.3 microdeletions increase risk of
1717idiopathic generalized epilepsy. Nat Genet 41(2):160–162
1718153. Steinlein OK, Bertrand D (2008) Neuronal nicotinic acetylcho-
1719line receptors: from the genetic analysis to neurological diseases.
1720Biochem Pharmacol 76(10):1175–1183
1721154. Brown LA et al (2006) Contributions from Caenorhabditis
1722elegans functional genetics to antiparasitic drug target identifica-
1723tion and validation: Nicotinic acetylcholine receptors, a case
1724study. Int J Parasitol 36(6):617–624
1725155. Ballivet M et al (1996) Nicotinic acetylcholine receptors in the
1726nematode Caenorhabditis elegans. J Mol Biol 258(2):261–269
1727156. Mongan NP et al (1998) An extensive and diverse gene family of
1728nicotinic acetylcholine receptor alpha subunits in Caenorhabditis
1729elegans. Recept Channels 6(3):213–228
1730157. Francis MM et al (2005) The Ror receptor tyrosine kinase CAM-
17311 is required for ACR-16-mediated synaptic transmission at the
1732C. elegans neuromuscular junction. Neuron 46(4):581–594
Mol Neurobiol
JrnlID 12035_ArtID 8434_Proof# 1 - 05/03/2013
AUTHOR'S PROOF
U
N
C
O
R
R
EC
TE
D
PR
O
O
F
1733 158. Farias GG et al (2007) Wnt-7a induces presynaptic
1734 colocalization of alpha 7-nicotinic acetylcholine receptors
1735 and adenomatous polyposis coli in hippocampal neurons. J
1736 Neurosci 27(20):5313–25
1737 159. Jensen M et al (2012) Wnt signaling regulates acetylcholine
1738 receptor translocation and synaptic plasticity in the adult nervous
1739 system. Cell 149(1):173–87
1740 160. Pevsner J, Hsu SC, Scheller RH (1994) n-Sec1: a neural-specific
1741 syntaxin-binding protein. Proc Natl Acad Sci U S A 91(4):1445–
1742 1449
1743 161. Hamdan FF et al (2009) De novo STXBP1 mutations in
1744 mental retardation and nonsyndromic epilepsy. Ann Neurol
1745 65(6):748–753
1746 162. Gengyo-Ando K et al (1993) TheC. elegans unc-18 gene encodes a
1747 protein expressed in motor neurons. Neuron 11(4):703–711
1748 163. Weimer RM et al (2003) Defects in synaptic vesicle docking in
1749 unc-18 mutants. Nat Neurosci 6(10):1023–1030
1750 164. McEwen JM, Kaplan JM (2008) UNC-18 promotes both the
1751 anterograde trafficking and synaptic function of syntaxin. Mol
1752 Biol Cell 19(9):3836–3846
1753 165. Wu MN et al (1999) Syntaxin 1A interacts with multiple exocytic
1754 proteins to regulate neurotransmitter release in vivo. Neuron
1755 23(3):593–605
1756 166. Gerber SH et al (2008) Conformational switch of syntaxin-1
1757 controls synaptic vesicle fusion. Science (New York, NY)
1758 321(5895):1507–1510
1759 167. Verhage M et al (2000) Synaptic assembly of the brain in the
1760 absence of neurotransmitter secretion. Science 287(5454):864–
1761 869
1762 168. Dobyns WB et al (1993) Lissencephaly. A human brain
1763 malformation associated with deletion of the LIS1 gene located
1764 at chromosome 17p13. JAMA 270(23):2838–42
1765 169. Kitamura K et al (2002) Mutation of ARX causes abnormal
1766 development of forebrain and testes in mice and X-linked
1767 lissencephaly with abnormal genitalia in humans. Nat Genet
1768 32(3):359–69
1769 170. Kumar RA et al (2010) TUBA1A mutations cause wide spectrum
1770 lissencephaly (smooth brain) and suggest that multiple neuronal
1771 migration pathways converge on alpha tubulins. Hum Mol Genet
1772 19(14):2817–2827
1773 171. Pilz DT et al (1998) LIS1 and XLIS (DCX) mutations cause most
1774 classical lissencephaly, but different patterns of malformation.
1775 Hum Mol Genet 7(13):2029–37
1776 172. Sossey-Alaoui K et al (1998) Human doublecortin (DCX) and the
1777 homologous gene in mouse encode a putative Ca2+−dependent
1778 signaling protein which is mutated in human X-linked neuronal
1779 migration defects. Hum Mol Genet 7(8):1327–32
1780 173. Jaglin XH, Chelly J (2009) Tubulin-related cortical dysgeneses:
1781 microtubule dysfunction underlying neuronal migration defects.
1782 Trends Genet 25(12):555–66
1783 174. Hong SE et al (2000) Autosomal recessive lissencephaly with
1784 cerebellar hypoplasia is associated with human RELN mutations.
1785 Nat Genet 26(1):93–6
1786 175. Locke CJ et al (2006) Genetic interactions among cortical
1787 malformation genes that influence susceptibility to convulsions
1788 in C. elegans. Brain Res 1120(1):23–34
1789 176. Locke CJ et al (2009) Pharmacogenetic analysis reveals a post-
1790 developmental role for Rac GTPases in Caenorhabditis elegans
1791 GABAergic neurotransmission. Genetics 183(4):1357–1372
1792 177. Evason K et al (2008) Valproic acid extends Caenorhabditis
1793 elegans lifespan. Aging Cell 7(3):305–17
1794 178. Evason K et al (2005) Anticonvulsant medications extend worm
1795 life-span. Science 307(5707):258–62
1796 179. Forthun RB et al (2012) Cross-species functional genomic
1797 analysis identifies resistance genes of the histone deacetylase
1798 inhibitor valproic acid. PLoS One 7(11):e48992
1799180. Palcoux JB, Niaudet P, Goumy P (1994) Side effects of levami-
1800sole in children with nephrosis. Pediatr Nephrol 8(2):263–4
1801181. Joly C et al (1998) Acute levamisole poisoning. Presse Med
180227(15):717
1803182. Jamain S et al (2003) Mutations of the X-linked genes encoding
1804neuroligins NLGN3 and NLGN4 are associated with autism. Nat
1805Genet 34(1):27–9
1806183. Laumonnier F et al (2004) X-linked mental retardation and
1807autism are associated with a mutation in the NLGN4 gene, a
1808member of the neuroligin family. Am J Hum Genet 74(3):552–7
1809184. Yan J et al (2008) Analysis of the neuroligin 4Y gene in patients
1810with autism. Psychiatr Genet 18(4):204–7
1811185. Sato D et al (2012) SHANK1 deletions in males with autism
1812spectrum disorder. Am J Hum Genet 90(5):879–87
1813186. Kim HG et al (2008) Disruption of neurexin 1 associated with
1814autism spectrum disorder. Am J Hum Genet 82(1):199–207
1815187. Calahorro F, Ruiz-Rubio M (2011) Caenorhabditis elegans as an
1816experimental tool for the study of complex neurological diseases:
1817Parkinson's disease, Alzheimer's disease and autism spectrum
1818disorder. Invertebr Neurosci 11(2):73–83
1819188. Calahorro F, Ruiz-Rubio M (2012) Functional phenotypic rescue
1820of Caenorhabditis elegans neuroligin-deficient mutants by the
1821human and rat NLGN1 genes. PLoS One 7(6):e39277–e39277
1822189. Calahorro, F., E. Alejandre, and M. Ruiz-Rubio, Osmotic avoid-
1823ance in Caenorhabditis elegans: synaptic function of two genes,
1824orthologues of human NRXN1 and NLGN1, as candidates for
1825autism. J Vis Exp, 2009(34)
1826190. Hunter JW et al (2010) Neuroligin-deficient mutants of C.
1827elegans have sensory processing deficits and are hypersensitive
1828to oxidative stress and mercury toxicity. Dis Model Mech
18293(5–6):366–376
1830191. Filipek PA et al (2000) Practice parameter: screening and diag-
1831nosis of autism: report of the Quality Standards Subcommittee of
1832the American Academy of Neurology and the Child Neurology
1833Society. Neurology 55(4):468–79
1834192. Chauhan A, Chauhan V (2006) Oxidative stress in autism.
1835Pathophysiology 13(3):171–81
1836193. Haklai-Topper L et al (2011) The neurexin superfamily of
1837Caenorhabditis elegans. Gene Expr Patterns 11(1–2):144–50
1838194. Naisbitt S et al (1999) Shank, a novel family of postsynaptic
1839density proteins that binds to the NMDA receptor/PSD-95/GKAP
1840complex and cortactin. Neuron 23(3):569–82
1841195. Sala C et al (2001) Regulation of dendritic spine morphology and
1842synaptic function by Shank and Homer. Neuron 31(1):115–30
1843196. Sala C et al (2005) Key role of the postsynaptic density scaffold
1844proteins Shank and Homer in the functional architecture of Ca2+
1845homeostasis at dendritic spines in hippocampal neurons. J
1846Neurosci 25(18):4587–92
1847197. Jee C et al (2004) SHN-1, a Shank homologue in C. elegans,
1848affects defecation rhythm via the inositol-1,4,5-trisphosphate
1849receptor. FEBS Lett 561(1–3):29–36
1850198. Oh WC et al (2011) ANK repeat-domain of SHN-1 Is indispens-
1851able for in vivo SHN-1 function in C. elegans. Mol Cells
185231(1):79–84
1853199. Hung AY et al (2008) Smaller dendritic spines, weaker synaptic
1854transmission, but enhanced spatial learning in mice lacking
1855Shank1. J Neurosci 28(7):1697–708
1856200. Castermans D et al (2003) The neurobeachin gene is disrupted by
1857a translocation in a patient with idiopathic autism. J Med Genet
185840(5):352–6
1859201. Wang X et al (2000) Neurobeachin: a protein kinase A-anchoring,
1860beige/Chediak-higashi protein homolog implicated in neuronal
1861membrane traffic. J Neurosci 20(23):8551–65
1862202. Medrihan L et al (2009) Neurobeachin, a protein implicated in
1863membrane protein traffic and autism, is required for the formation
1864and functioning of central synapses. J Physiol 587(Pt 21):5095–106
Mol Neurobiol
JrnlID 12035_ArtID 8434_Proof# 1 - 05/03/2013
AUTHOR'S PROOF
U
N
C
O
R
R
EC
TE
D
PR
O
O
F
1865 203. Volders K, Nuytens K, Creemers JW (2011) The autism candidate
1866 gene Neurobeachin encodes a scaffolding protein implicated
1867 in membrane trafficking and signaling. Curr Mol Med
1868 11(3):204–17
1869 204. de Souza N et al (2007) SEL-2, the C. elegans neurobeachin/
1870 LRBA homolog, is a negative regulator of lin-12/Notch activity
1871 and affects endosomal traffic in polarized epithelial cells.
1872 Development 134(4):691–702
1873 205. Shamloula HK et al (2002) rugose (rg), a Drosophila A kinase
1874 anchor protein, is required for retinal pattern formation and
1875 interacts genetically with multiple signaling pathways. Genetics
1876 161(2):693–710
1877 206. Katidou M et al (2008) The immunoglobulin superfamily of
1878 neuronal cell adhesion molecules: lessons from animal models
1879 and correlation with human disease. Biotechnol J 3(12):1564–80
1880 207. Rosenthal A, Jouet M, Kenwrick S (1992) Aberrant splicing of
1881 neural cell adhesion molecule L1 mRNA in a family with X-
1882 linked hydrocephalus. Nat Genet 2(2):107–12
1883 208. Jouet M et al (1993) A missense mutation confirms the L1 defect
1884 in X-linked hydrocephalus (HSAS). Nat Genet 4(4):331
1885 209. Fransen E et al (1995) CRASH syndrome: clinical spectrum of
1886 corpus callosum hypoplasia, retardation, adducted thumbs,
1887 spastic paraparesis and hydrocephalus due to mutations in one
1888 single gene, L1. Eur J Hum Genet 3(5):273–84
1889 210. Marui T et al (2009) Association of the neuronal cell
1890 adhesion molecule (NRCAM) gene variants with autism.
1891 Int J Neuropsychopharmacol 12(1):1–10
1892 211. Zallen JA, Kirch SA, Bargmann CI (1999) Genes required for
1893 axon pathfinding and extension in the C. elegans nerve ring.
1894 Development 126(16):3679–92
1895 212. Wang X et al (2005) A role for the C. elegans L1CAM
1896 homologue lad-1/sax-7 in maintaining tissue attachment. Dev
1897 Biol 284(2):273–91
1898 213. Sasakura H et al (2005) Maintenance of neuronal positions in
1899 organized ganglia by SAX-7, a Caenorhabditis elegans
1900 homologue of L1. EMBO J 24(7):1477–88
1901 214. Pocock R et al (2008) Functional dissection of the C. elegans cell
1902 adhesion molecule SAX-7, a homologue of human L1. Mol Cell
1903 Neurosci 37(1):56–68
1904 215. Wang X et al (2008) The C. elegans L1CAM homologue LAD-2
1905 functions as a coreceptor in MAB-20/Sema2 mediated axon
1906 guidance. J Cell Biol 180(1):233–46
1907 216. Castellani V et al (2000) Analysis of the L1-deficient mouse
1908 phenotype reveals cross-talk between Sema3A and L1 signaling
1909 pathways in axonal guidance. Neuron 27(2):237–49
1910 217. Falk J et al (2005) Dual functional activity of semaphorin
1911 3B is required for positioning the anterior commissure. Neuron
1912 48(1):63–75
1913 218. Wright AG et al (2007) Close homolog of L1 and neuropilin 1
1914 mediate guidance of thalamocortical axons at the ventral
1915 telencephalon. J Neurosci 27(50):13667–79
1916 219. Demyanenko GP, Shibata Y, Maness PF (2001) Altered distribu-
1917 tion of dopaminergic neurons in the brain of L1 null mice. Brain
1918 Res Dev Brain Res 126(1):21–30
1919 220. Demyanenko GP et al (2004) Close homolog of L1 modulates
1920 area-specific neuronal positioning and dendrite orientation in the
1921 cerebral cortex. Neuron 44(3):423–37
1922 221. Demyanenko GP et al (2011) NrCAM deletion causes topograph-
1923 ic mistargeting of thalamocortical axons to the visual cortex and
1924 disrupts visual acuity. J Neurosci 31(4):1545–58
1925 222. Macosko EZ et al (2009) A hub-and-spoke circuit drives
1926 pheromone attraction and social behaviour in C. elegans. Nature
1927 458(7242):1171–1175
1928 223. Wu Q et al (2003) Developmental control of foraging and social
1929 behavior by the Drosophila neuropeptide Y-like system. Neuron
1930 39(1):147–61
1931224. Karl T et al (2010) Schizophrenia-relevant behaviours in a genetic
1932mouse model for Y2 deficiency. Behav Brain Res 207(2):434–40
1933225. Ramanathan S et al (2004) A case of autism with an interstitial
1934deletion on 4q leading to hemizygosity for genes encoding for
1935glutamine and glycine neurotransmitter receptor sub-units
1936(AMPA 2, GLRA3, GLRB) and neuropeptide receptors NPY1R,
1937NPY5R. BMC Med Genet 5:10
1938226. Kramer JM, van Bokhoven H (2009) Genetic and epigenetic defects
1939in mental retardation. Int J Biochem Cell Biol 41(1):96–107
1940227. Bond J et al (2002) ASPM is a major determinant of cerebral
1941cortical size. Nat Genet 32(2):316–320
1942228. Higgins J et al (2010) Human ASPM participates in spindle
1943organisation, spindle orientation and cytokinesis. BMC Cell Biol
194411:85–85
1945229. van der Voet M et al (2009) NuMA-related LIN-5, ASPM-1,
1946calmodulin and dynein promote meiotic spindle rotation indepen-
1947dently of cortical LIN-5/GPR/Galpha. Nat Cell Biol 11(3):269–
1948277
1949230. Galli M et al (2011) aPKC phosphorylates NuMA-related LIN-5
1950to position the mitotic spindle during asymmetric division. Nat
1951Cell Biol 13(9):1132–1138
1952231. Fraser AG et al (2000) Functional genomic analysis of C.
1953elegans chromosome I by systematic RNA interference. Nature
1954408(6810):325–330
1955232. Simmer F et al (2003) Genome-wide RNAi of C. elegans using
1956the hypersensitive rrf-3 strain reveals novel gene functions. PLoS
1957Biol 1(1):E12–E12
1958233. Piano F et al (2002) Gene clustering based on RNAi phenotypes
1959of ovary-enriched genes in C. elegans. Curr Biol 12(22):1959–
19601964
1961234. Pulvers JN et al (2010) Mutations in mouse Aspm (abnormal
1962spindle-like microcephaly associated) cause not only microceph-
1963aly but also major defects in the germline. Proc Natl Acad Sci U S
1964A 107(38):16595–16600
1965235. Laumonnier F et al (2005) Mutations in PHF8 are associated with
1966X linked mental retardation and cleft lip/cleft palate. J Med Genet
196742(10):780–786
1968236. Koivisto AM et al (2007) Screening of mutations in the PHF8
1969gene and identification of a novel mutation in a Finnish family
1970with XLMR and cleft lip/cleft palate. Clin Genet 72(2):145–149
1971237. Qiu J et al (2010) The X-linked mental retardation gene PHF8 is a
1972histone demethylase involved in neuronal differentiation. Cell
1973Res 20(8):908–918
1974238. Kleine-Kohlbrecher D et al (2010) A functional link between the
1975histone demethylase PHF8 and the transcription factor ZNF711 in
1976X-linked mental retardation. Mol Cell 38(2–2):165–178
1977239. Stromme P et al (2002) Mutations in the human ortholog of
1978Aristaless cause X-linked mental retardation and epilepsy. Nat
1979Genet 30(4):441–5
1980240. Melkman T, Sengupta P (2005) Regulation of chemosensory and
1981GABAergic motor neuron development by the C. elegans
1982Aristaless/Arx homolog alr-1. Development 132(8):1935–49
1983241. Poirier K et al (2007) Large spectrum of lissencephaly and
1984pachygyria phenotypes resulting from de novo missense muta-
1985tions in tubulin alpha 1A (TUBA1A). Hum Mutat 28(11):1055–
198664
1987242. Baran R et al (2010) Motor neuron synapse and axon defects in a
1988C. elegans alpha-tubulin mutant. PLoS One 5(3):e9655
1989243. Epstein CJ (2006) Down's syndrome: critical genes in a critical
1990region. Nature 441(7093):582–583
1991244. Guipponi M et al (2000) C21orf5, a novel human chromosome 21
1992gene, has a Caenorhabditis elegans ortholog (pad-1) required for
1993embryonic patterning. Genomics 68(1):30–40
1994245. Rachidi M et al (2007) New cerebellar phenotypes in YAC
1995transgenic mouse in vivo library of human Down syndrome
1996critical region-1. Biochem Biophys Res Commun 364(3):488–94
Mol Neurobiol
JrnlID 12035_ArtID 8434_Proof# 1 - 05/03/2013
AUTHOR'S PROOF
U
N
C
O
R
R
EC
TE
D
PR
O
O
F
1997 246. Rachidi M, Lopes C (2008) Mental retardation and associated
1998 neurological dysfunctions in Down syndrome: a consequence of
1999 dysregulation in critical chromosome 21 genes and associated
2000 molecular pathways. Eur J Paediatr Neurol EJPN Off J Eur
2001 Paediatr Neurol Soc 12(3):168–182
2002 247. Arron JR et al (2006) NFAT dysregulation by increased dosage of
2003 DSCR1 and DYRK1A on chromosome 21. Nature 441(7093):595–
2004 600
2005 248.Q2 Dierssen M, de Lagrån MMN (2006) DYRK1A (dual-specificity
2006 tyrosine-phosphorylated and -regulated kinase 1A): a gene with
2007 dosage effect during development and neurogenesis. Sci World J
2008 6:1911–1922
2009 249. Park J, Song W-J, Chung K (2009) Function and regulation of
2010 Dyrk1A: towards understanding Down syndrome. Cell Mol Life
2011 Sci 66(20):3235–3240
2012 250. Raich WB et al (2003) Characterization of Caenorhabditis
2013 elegans homologs of the Down syndrome candidate gene
2014 DYRK1A. Genetics 163(2):571–580
2015 251. Altafaj, X., et al., Normalization of Dyrk1A expression by AAV2/
2016 1-shDyrk1A attenuates hippocampal-dependent defects in the
2017 Ts65Dn mouse model of Down syndrome. Neurobiol Dis, 2012
2018 252. Guedj F et al (2009) Green tea polyphenols rescue of brain defects
2019 induced by overexpression of DYRK1A. PLoS One 4(2):e4606
2020 253. Ortiz-Abalia J et al (2008) Targeting Dyrk1A with AAVshRNA
2021 attenuates motor alterations in TgDyrk1A, a mouse model of
2022 Down syndrome. Am J Hum Genet 83(4):479–88
2023 254. Strippoli P et al (2000) A new gene family including DSCR1
2024 (Down syndrome candidate region 1) and ZAKI-4: characteriza-
2025 tion from yeast to human and identification of DSCR1-like 2, a
2026 novel human member (DSCR1L2). Genomics 64(3):252–263
2027 255. Fuentes JJ et al (2000) DSCR1, overexpressed in Down
2028 syndrome, is an inhibitor of calcineurin-mediated signaling
2029 pathways. Hum Mol Genet 9(11):1681–1690
2030 256. Groth RD, Dunbar RL, Mermelstein PG (2003) Calcineurin
2031 regulation of neuronal plasticity. Biochem Biophys Res Commun
2032 311(4):1159–1171
2033 257. Nguyen T, Di Giovanni S (2008) NFAT signaling in neural
2034 development and axon growth. Int J Dev Neurosci Off J Int Soc
2035 Dev Neurosci 26(2):141–145
2036 258. Lee JI et al (2003) The Caenorhabditis elegans homologue of
2037 Down syndrome critical region 1, RCN-1, inhibits multiple func-
2038 tions of the phosphatase calcineurin. J Mol Biol 328(1):147–156
2039 259. Kalscheuer VM et al (2003) Mutations in the polyglutamine
2040 binding protein 1 gene cause X-linked mental retardation. Nat
2041 Genet 35(4):313–315
2042 260. Lenski C et al (2004) Novel truncating mutations in the
2043 polyglutamine tract binding protein 1 gene (PQBP1) cause
2044 Renpenning syndrome and X-linked mental retardation in another
2045 family with microcephaly. Am J Hum Genet 74(4):777–780
2046 261. Lubs H et al (2006) Golabi-to-Hall syndrome results from a
2047 missense mutation in the WW domain of the PQBP1 gene. J
2048 Med Genet 43(6):e30–e30
2049 262. Takahashi, K., et al., Nematode homologue of PQBP1, a mental
2050 retardation causative gene, is involved in lipid metabolism. PLoS
2051 One, 2009. 4(1)
2052 263. Gibbons RJ et al (1995) Mutations in a putative global transcrip-
2053 tional regulator cause X-linked mental retardation with alpha-
2054 thalassemia (ATR-X syndrome). Cell 80(6):837–845
2055 264. Gibbons R (2006) Alpha thalassaemia-mental retardation, X
2056 linked. Orphanet J Rare Dis 1:15–15
2057 265. Picketts DJ et al (1996) ATRX encodes a novel member of the SNF2
2058 family of proteins: mutations point to a common mechanism under-
2059 lying the ATR-X syndrome. Hum Mol Genet 5(12):1899–1907
2060 266. Kernohan KD et al (2010) ATRX partners with cohesin and
2061 MeCP2 and contributes to developmental silencing of imprinted
2062 genes in the brain. Dev Cell 18(2):191–202
2063267. Bender AM, Wells O, Fay DS (2004) lin-35/Rb and xnp-1/ATR-
2064X function redundantly to control somatic gonad development in
2065C. elegans. Dev Biol 273(2):335–349
2066268. Cardoso C et al (2005) XNP-1/ATR-X acts with RB, HP1 and the
2067NuRD complex during larval development in C. elegans. Dev
2068Biol 278(1):49–59
2069269. Chubb JE et al (2008) The DISC locus in psychiatric illness. Mol
2070Psychiatry 13(1):36–64
2071270. Soares DC et al (2011) DISC1: structure, function, and therapeu-
2072tic potential for major mental illness. ACS Chem Neurosci
20732(11):609–632
2074271. Chen S-Y, Huang P-H, Cheng H-J (2011) Disrupted-in-
2075schizophrenia 1-mediated axon guidance involves TRIO-RAC-
2076PAK small GTPase pathway signaling. Proc Natl Acad Sci U S A
2077108(14):5861–5866
2078272. Briancon-Marjollet A et al (2008) Trio mediates netrin-1-induced
2079Rac1 activation in axon outgrowth and guidance. Mol Cell Biol
208028(7):2314–23
2081273. Kwok TC et al (2006) A small-molecule screen in C. elegans
2082yields a new calcium channel antagonist. Nature 441(7089):91–5
2083274. Calamini B et al (2012) Small-molecule proteostasis regulators
2084for protein conformational diseases. Nat Chem Biol 8(2):185–96
2085275. Wormbase. Available from: http://www.wormbase.org.
2086276. Rijkers K et al (2010) Polymorphisms in CACNA1E and
2087Camk2d are associated with seizure susceptibility of Sprague–
2088Dawley rats. Epilepsy Res 91(1):28–34
2089277. Genetics home reference. Available from: http://ghr.nlm.nih.gov/gene/
2090278. Liu Q, Hollopeter G, Jorgensen EM (2009) Graded synaptic
2091transmission at the Caenorhabditis elegans neuromuscular
2092junction. Proc Natl Acad Sci USA 106(26):10823–8
2093279. Thorgeirsson TE et al (2008) A variant associated with nicotine
2094dependence, lung cancer and peripheral arterial disease. Nature
2095452(7187):638–42
2096280. Saitsu H et al (2008) De novo mutations in the gene encoding
2097STXBP1 (MUNC18-1) cause early infantile epileptic encepha-
2098lopathy. Nat Genet 40(6):782–8
2099281. Bellanger JM et al (2012) The doublecortin-related gene zyg-8 is
2100a microtubule organizer in Caenorhabditis elegans neurons. J
2101Cell Sci 125(Pt 22):5417–27
2102282. Gonczy P et al (2001) zyg-8, a gene required for spindle
2103positioning in C. elegans, encodes a doublecortin-related kinase
2104that promotes microtubule assembly. Dev Cell 1(3):363–75
2105283. Ackman JB et al (2009) Abnormal network activity in a
2106targeted genetic model of human double cortex. J Neurosci
210729(2):313–27
2108284. Kerjan G et al (2009) Mice lacking doublecortin and
2109doublecortin-like kinase 2 display altered hippocampal neu-
2110ronal maturation and spontaneous seizures. Proc Natl Acad
2111Sci USA 106(16):6766–71
2112285. Alkuraya FS et al (2011) Human mutations in NDE1 cause
2113extreme microcephaly with lissencephaly [corrected]. Am J
2114Hum Genet 88(5):536–47
2115286. Willemsen MH et al (2012) Mutations in DYNC1H1 cause severe
2116intellectual disability with neuronal migration defects. J Med
2117Genet 49(3):179–83
2118287. Fu AK et al (2005) Aberrant motor axon projection, acetylcholine
2119receptor clustering, and neurotransmission in cyclin-dependent
2120kinase 5 null mice. Proc Natl Acad Sci USA 102(42):15224–9
2121288. Chae T et al (1997) Mice lacking p35, a neuronal specific acti-
2122vator of Cdk5, display cortical lamination defects, seizures, and
2123adult lethality. Neuron 18(1):29–42
2124289. Topalidou I, van Oudenaarden A, Chalfie M (2011)Caenorhabditis
2125elegans aristaless/Arx gene alr-1 restricts variable gene expression.
2126Proc Natl Acad Sci U S A 108(10):4063–4068
2127290. Tucker M et al (2005) The Caenorhabditis elegans aristaless
2128orthologue, alr-1, is required for maintaining the functional and
Mol Neurobiol
JrnlID 12035_ArtID 8434_Proof# 1 - 05/03/2013
AUTHOR'S PROOF
U
N
C
O
R
R
EC
TE
D
PR
O
O
F
2129 structural integrity of the amphid sensory organs. Mol Biol Cell
2130 16(10):4695–4704
2131 291. Gloria-Soria A, Azevedo RBR (2008) npr-1 regulates foraging
2132 and dispersal strategies in Caenorhabditis elegans. Curr Biol
2133 18(21):1694–1699
2134 292. Rogers C et al (2003) Inhibition of Caenorhabditis elegans social
2135 feeding by FMRFamide-related peptide activation of NPR-1. Nat
2136 Neurosci 6(11):1178–1185
2137 293. Asada H et al (1996) Mice lacking the 65 kDa isoform of
2138 glutamic acid decarboxylase (GAD65) maintain normal
2139 levels of GAD67 and GABA in their brains but are suscep-
2140 tible to seizures. Biochem Biophys Res Commun 229(3):891–
2141 5
2142 294. Kulkarni SJ, Newby LM, Jackson FR (1994) Drosophila
2143 GABAergic systems. II. Mutational analysis of chromosomal
2144segment 64AB, a region containing the glutamic acid decarbox-
2145ylase gene. Mol Gen Genet 243(5):555–64
2146295. Cossette P et al (2002) Mutation of GABRA1 in an autosomal
2147dominant form of juvenile myoclonic epilepsy. Nat Genet
214831(2):184–9
2149296. DeLorey TM et al (1998) Mice lacking the beta3 subunit of the
2150GABAA receptor have the epilepsy phenotype and many of the
2151behavioral characteristics of Angelman syndrome. J Neurosci
215218(20):8505–14
2153297. Schuler V et al (2001) Epilepsy, hyperalgesia, impaired memory,
2154and loss of pre- and postsynaptic GABA(B) responses in mice
2155lacking GABA(B(1)). Neuron 31(1):47–58
2156298. Lee D, Su H, O'Dowd DK (2003) GABA receptors containing
2157Rdl subunits mediate fast inhibitory synaptic transmission in
2158Drosophila neurons. J Neurosci 23(11):4625–34
2159
Mol Neurobiol
JrnlID 12035_ArtID 8434_Proof# 1 - 05/03/2013
AUTHOR'S PROOF
U
N
C
O
R
R
EC
TE
D
PR
O
O
F
AUTHOR QUERIES
AUTHOR PLEASE ANSWER ALL QUERIES.
Q1. References 152 and 279 based on original manuscript we received were identical. Hence, the
latter was deleted and reference list and citations were adjusted. Please check if appropriate.
Q2. Please check provided bibauthorname if correct.
